Cabergoline
| Title | Journal |
|---|---|
| Why are most phospholipidosis inducers also hERG blockers? | Archives of toxicology 20171201 |
| A cross-sectional study of the prevalence of cardiac valvular abnormalities in hyperprolactinemic patients treated with ergot-derived dopamine agonists. | The Journal of clinical endocrinology and metabolism 20140101 |
| Treatment of ovarian hyperstimulation syndrome using gonadotropin releasing hormone antagonist: a pilot study. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20121101 |
| Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients. | European journal of endocrinology 20121101 |
| Effect of antiangiogenic treatment on peritoneal endometriosis-associated nerve fibers. | Fertility and sterility 20121101 |
| European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society. | European journal of neurology 20121101 |
| Polymorphisms of the drug transporter gene ABCB1 predict side effects of treatment with cabergoline in patients with PRL adenomas. | European journal of endocrinology 20120901 |
| No evidence of a detrimental effect of cabergoline therapy on cardiac valves in patients with acromegaly. | The Journal of clinical endocrinology and metabolism 20120901 |
| No clinically significant valvular regurgitation in long-term cabergoline treatment for prolactinoma. | Clinical endocrinology 20120801 |
| How to investigate and treat: headache and hyperprolactinemia. | Current pain and headache reports 20120801 |
| The treatment of restless legs syndrome and periodic limb movement disorder in adults--an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. | Sleep 20120801 |
| Cabergoline effect on blood sugar in type 2 diabetic patients with oral agent failure. | The Medical journal of Malaysia 20120801 |
| Changes in heart valve structure and function in patients treated with dopamine agonists for prolactinomas, a 2-year follow-up study. | Clinical endocrinology 20120701 |
| Increased prevalence of subclinical cardiac valve fibrosis in patients with prolactinomas on long-term bromocriptine and cabergoline treatment. | European journal of endocrinology 20120701 |
| [Hyperprolactin as cause of hypoactive sexual desire in men]. | Ugeskrift for laeger 20120618 |
| Macroprolactinomas presenting as nasal polyps: a series of three cases. | Irish journal of medical science 20120601 |
| Risk assessment and follow-up of valvular regurgitation in Parkinson patients treated with cabergoline. | Parkinsonism & related disorders 20120601 |
| Finasteride attenuates pathological gambling in patients with Parkinson disease. | Journal of clinical psychopharmacology 20120601 |
| [Gender effect on cardiomyopathy]. | Giornale italiano di cardiologia (2006) 20120601 |
| Endocrinological outcomes of pure endoscopic transsphenoidal surgery: a Croatian Referral Pituitary Center experience. | Croatian medical journal 20120601 |
| Somatostatin receptor sst2 gene transfer in human prolactinomas in vitro: impact on sensitivity to dopamine, somatostatin and dopastatin, in the control of prolactin secretion. | Molecular and cellular endocrinology 20120515 |
| Heart valve disease among patients with hyperprolactinemia: a nationwide population-based cohort study. | The Journal of clinical endocrinology and metabolism 20120501 |
| Comparison of the use of cabergoline and gonadotrophin to treat primary and secondary anoestrus in bitches. | Australian veterinary journal 20120501 |
| [Prescription of ergot derivatives for lactation inhibition in France: Current practices]. | Journal de gynecologie, obstetrique et biologie de la reproduction 20120401 |
| Randomized pilot study of cabergoline, a dopamine receptor agonist: effects on body weight and glucose tolerance in obese adults. | Diabetes, obesity & metabolism 20120401 |
| Effective combination treatment with cabergoline and low-dose pegvisomant in active acromegaly: a prospective clinical trial. | The Journal of clinical endocrinology and metabolism 20120401 |
| The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy. | The Journal of clinical endocrinology and metabolism 20120401 |
| 2012 update in the treatment of prolactinomas. | Annales d'endocrinologie 20120401 |
| Temozolomide in aggressive pituitary adenomas and carcinomas. | Clinics (Sao Paulo, Brazil) 20120401 |
| Safety of cabergoline in the management of pituitary prolactin-induced symptoms with patients treated with atypical neuroleptics. | Current drug safety 20120401 |
| Long term follow-up of patients with prolactinomas and outcome of dopamine agonist withdrawal: a single center experience. | Pituitary 20120301 |
| Improvement of cardiac parameters in patients with acromegaly treated with medical therapies. | Pituitary 20120301 |
| A comparison of cabergoline and bromocriptine on the risk of valvular heart disease in patients with prolactinomas. | Pituitary 20120301 |
| Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogues and dopastatins. | Clinical endocrinology 20120301 |
| Comparison of cabergoline and intravenous albumin in the prevention of ovarian hyperstimulation syndrome: a randomized clinical trial. | Journal of assisted reproduction and genetics 20120301 |
| Cabergoline for preventing ovarian hyperstimulation syndrome. | The Cochrane database of systematic reviews 20120215 |
| A case of an ectopic prolactinoma. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20120201 |
| Mifepristone effects on tumor somatostatin receptor expression in two patients with Cushing's syndrome due to ectopic adrenocorticotropin secretion. | The Journal of clinical endocrinology and metabolism 20120201 |
| An unusual case of ectopic ACTH syndrome. | Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20120201 |
| Von Hippel-Lindau disease and aggressive GH-PRL pituitary adenoma in a young boy. | Annales d'endocrinologie 20120201 |
| The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients. | The Kaohsiung journal of medical sciences 20120201 |
| Hypogonadism due to hyperprolactinemia and subsequent first episode of psychosis. | Gender medicine 20120201 |
| Advances in medical therapies for Cushing's syndrome. | Discovery medicine 20120201 |
| Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism. | Neuron 20120126 |
| Dopamine agonists and ischemic complications in Parkinson's disease: a nested case-control study. | European journal of clinical pharmacology 20120101 |
| Discontinuation of octreotide LAR after long term, successful treatment of patients with acromegaly: is it worth trying? | European journal of endocrinology 20120101 |
| Dopamine agonist use and the risk of heart failure. | Pharmacoepidemiology and drug safety 20120101 |
| Neurocognitive correlates of apathy and anxiety in Parkinson's disease. | Parkinson's disease 20120101 |
| Pamidronic acid and cabergoline as effective long-term therapy in a 12-year-old girl with extended facial polyostotic fibrous dysplasia, prolactinoma and acromegaly in McCune-Albright syndrome: a case report. | Journal of medical case reports 20120101 |
| Risk of falls in Parkinson's disease: a cross-sectional study of 160 patients. | Parkinson's disease 20120101 |
| Association of dengue hemorrhagic fever with multiple risk factors for pituitary apoplexy. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20120101 |
| Lanreotide depot deep subcutaneous injection: a new method of delivery and its associated benefits. | Patient preference and adherence 20120101 |
| Treatment Options in Cushing's Disease. | Clinical Medicine Insights. Oncology 20120101 |
| Dopaminergic Control of the Exploration-Exploitation Trade-Off via the Basal Ganglia. | Frontiers in neuroscience 20120101 |
| Computed three-dimensional atlas of subthalamic nucleus and its adjacent structures for deep brain stimulation in Parkinson's disease. | ISRN neurology 20120101 |
| Spontaneous coronary artery dissection during cabergoline therapy. | Texas Heart Institute journal 20120101 |
| The first case of Brucella canis in Sweden: background, case report and recommendations from a northern European perspective. | Acta veterinaria Scandinavica 20120101 |
| Hyperprolactinemia as a rare cause of hypertension in chronic renal failure. | Renal failure 20120101 |
| Congenital cystic adenomatoid malformation: is there a need for pregnancy termination? | Case reports in medicine 20120101 |
| Surgery and radiosurgery for acromegaly: a review of indications, operative techniques, outcomes, and complications. | International journal of endocrinology 20120101 |
| Gamma knife radiosurgery for acromegaly. | International journal of endocrinology 20120101 |
| Innovative oral treatments of uterine leiomyoma. | Obstetrics and gynecology international 20120101 |
| Long-term effects of cabergoline and levodopa in Japanese patients with early Parkinson's disease: a 5-year prospective study. | Acta medica Okayama 20120101 |
| Medical therapy of acromegaly. | International journal of endocrinology 20120101 |
| Dopamine agonists and pathologic behaviors. | Parkinson's disease 20120101 |
| Ectopic prolactinoma within the sphenoidal sinus associated with empty sella. | Surgical neurology international 20120101 |
| Optimal effective doses of cabergoline and bromocriptine and valvular leasions in men with prolactinomas. | Neuro endocrinology letters 20120101 |
| McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasia. | Orphanet journal of rare diseases 20120101 |
| Treatment-resistant Schizophrenia: Evidence-based Strategies. | Mens sana monographs 20120101 |
| Parallel appearance of compulsive behaviors and artistic creativity in Parkinson's disease. | Case reports in neurology 20120101 |
| Attentional set-shifting deficit in Parkinson's disease is associated with prefrontal dysfunction: an FDG-PET study. | PloS one 20120101 |
| [Approaching the 'evidence-practice gap' in pharmaceutical risk management: analysis of healthcare claim data]. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20120101 |
| Clinical aspects and management of levodopa-induced dyskinesia. | Parkinson's disease 20120101 |
| Dramatic shrinkage of a giant prolactinoma in a male patient under medical management. | Acta clinica Belgica 20120101 |
| Disappearance of pituitary macro adenoma with combination of ketoconazole and cabergoline treatment: an unusual case of Cushing's syndrome with interesting findings. | BMJ case reports 20120101 |
| Treatment of hyperprolactinemia: a systematic review and meta-analysis. | Systematic reviews 20120101 |
| Obstructive hydrocephalus, fifth nerve and hypothalamus involvement: acute presentation of a giant prolactinoma. | Clinical medicine insights. Case reports 20120101 |
| Cluster headache secondary to macroprolactinoma with ipsilateral cavernous sinus invasion. | Case reports in neurological medicine 20120101 |
| Dopamine agonists upregulate IL-6 and IL-8 production in human keratinocytes. | Neuroimmunomodulation 20120101 |
| Spontaneous reduction of prolactinoma post cabergoline withdrawal. | Indian journal of endocrinology and metabolism 20120101 |
| Efficacy of the combined cabergoline and octreotide treatment in a case of a dopamine-agonist resistant macroprolactinoma. | Pituitary 20111201 |
| Secondary resistance to cabergoline therapy in a macroprolactinoma: a case report and literature review. | Pituitary 20111201 |
| Brain and optic chiasmal herniations into sella after cabergoline therapy of giant prolactinoma. | Pituitary 20111201 |
| Regression of cardiac valvulopathy related to ergot-derived dopamine agonists. | Cardiovascular therapeutics 20111201 |
| High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas. | Pituitary 20111201 |
| Giant prolactinoma causing cranio-cervical junction instability: a case report. | British journal of neurosurgery 20111201 |
| Human cognitive flexibility depends on dopamine D2 receptor signaling. | Psychopharmacology 20111201 |
| Prolactinoma in pregnancy. | Best practice & research. Clinical endocrinology & metabolism 20111201 |
| [Cabergoline-induced tension pneumocephalus in a patient with giant invasive prolactinoma. Case report]. | Neurocirugia (Asturias, Spain) 20111201 |
| Spontaneous bacterial peritonitis complicating ovarian hyperstimulation syndrome-related ascites. | Clinics (Sao Paulo, Brazil) 20111201 |
| Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). | PLoS computational biology 20111201 |
| Reversible cardiac valve fibrosis secondary to treatment with high-dose cabergoline for Parkinson's disease. | Journal of neurology 20111101 |
| The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis. | Reproduction (Cambridge, England) 20111101 |
| Prolactin in men's health and disease. | Current opinion in urology 20111101 |
| [Prolactinoma treatment status in the cabergoline era]. | No shinkei geka. Neurological surgery 20111101 |
| Effects of aerobic exercise in the management of erectile dysfunction: a meta analysis study on randomized controlled trials. | Ethiopian journal of health sciences 20111101 |
| The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease. | Movement disorders : official journal of the Movement Disorder Society 20111001 |
| Pediatric suprasellar lesions. | Journal of pediatric neurosciences 20111001 |
| Endocrine hypertension - Cushing's syndrome. | Indian journal of endocrinology and metabolism 20111001 |
| The effect of cabergoline on clinical and laboratory findings in active rheumatoid arthritis. | Iranian Red Crescent medical journal 20111001 |
| Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonists. | Pituitary 20110901 |
| Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: a systematic review of randomized controlled trials and meta-analysis. | Pituitary 20110901 |
| Functional potencies of dopamine agonists and antagonists at human dopamine D₂ and D₃ receptors. | European journal of pharmacology 20110901 |
| Extralabel use of cabergoline in the treatment of a pituitary adenoma in a rat. | Journal of the American Veterinary Medical Association 20110901 |
| Recovery pattern of hypothalamo-pituitary-testicular axis in patients with macroprolactinomas after treatment with cabergoline. | The Indian journal of medical research 20110901 |
| Anesthesia and Intensive care implications for pituitary surgery: Recent trends and advancements. | Indian journal of endocrinology and metabolism 20110901 |
| Management of prolactinoma with cabergoline treatment in a pregnant woman during her entire pregnancy. | Indian journal of endocrinology and metabolism 20110901 |
| Neuromodulatory neurotransmitters influence LTP-like plasticity in human cortex: a pharmaco-TMS study. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20110801 |
| Evidences for the existence of a low dopaminergic tone in polycystic ovarian syndrome: implications for OHSS development and treatment. | The Journal of clinical endocrinology and metabolism 20110801 |
| [Pathological gambling induced by dopamine agonists]. | Fortschritte der Neurologie-Psychiatrie 20110801 |
| Update on the withdrawal of dopamine agonists in patients with hyperprolactinemia. | Current opinion in endocrinology, diabetes, and obesity 20110801 |
| Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control study. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110701 |
| Results of endoscopic transsphenoidal pituitary surgery in 40 patients with a growth hormone-secreting macroadenoma. | Acta neurochirurgica 20110701 |
| The intravaginal application of misoprostol improves induction of abortion with aglepristone. | Theriogenology 20110701 |
| The bulky N6 substituent of cabergoline is responsible for agonism of this drug at 5-hydroxytryptamine 5-HT2A and 5-HT2B receptors and thus is a determinant of valvular heart disease. | The Journal of pharmacology and experimental therapeutics 20110701 |
| Treatment in late Parkinson's disease. | Annals of Indian Academy of Neurology 20110701 |
| Psychosis in Parkinson's disease. | Annals of Indian Academy of Neurology 20110701 |
| Initiation of treatment in early PD (evidences based). | Annals of Indian Academy of Neurology 20110701 |
| In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5. | Pituitary 20110601 |
| Role of the addition of cabergoline to the management of acromegalic patients resistant to longterm treatment with octreotide LAR. | Pituitary 20110601 |
| Soluble CD40 ligand and prolactin levels in migraine patients during interictal period. | The journal of headache and pain 20110601 |
| Vertebral fractures in males with prolactinoma. | Endocrine 20110601 |
| Chronic anemia as first clinical manifestation of a prolactin-secreting pituitary macroadenoma in a male patient. | The American journal of medicine 20110601 |
| Clinical course of hyperprolactinemia in children and adolescents: a review of 21 cases. | Journal of clinical research in pediatric endocrinology 20110601 |
| Medical management of Parkinson's disease: focus on neuroprotection. | Current neuropharmacology 20110601 |
| Cardiac valve disease and low-dose dopamine agonist therapy: an artefact of reporting bias? | Clinical endocrinology 20110501 |
| Utilization of anti-Parkinson drugs in Australia: 1995-2009. | Pharmacoepidemiology and drug safety 20110501 |
| Place of cabergoline in acromegaly: a meta-analysis. | The Journal of clinical endocrinology and metabolism 20110501 |
| Pituitary tumors: cabergoline versus bromocriptine: a meta-analysis? | Nature reviews. Endocrinology 20110501 |
| Brain 5-HT(2A) receptors in MPTP monkeys and levodopa-induced dyskinesias. | The European journal of neuroscience 20110501 |
| BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists. | Obesity (Silver Spring, Md.) 20110401 |
| The impact in Japan of regulatory action on prescribing of dopamine receptor agonists: analysis of a claims database between 2005 and 2008. | Drug safety 20110401 |
| The risk of valvular regurgitation in patients with Parkinson's disease treated with dopamine receptor agonists. | Movement disorders : official journal of the Movement Disorder Society 20110401 |
| Dopamine agonists for restless legs syndrome. | The Cochrane database of systematic reviews 20110316 |
| Anemia in a cohort of men with macroprolactinomas: increase in hemoglobin levels follows prolactin suppression. | Pituitary 20110301 |
| Effect of dopaminergic drug treatment on surgical findings in prolactinomas. | Pituitary 20110301 |
| Disorganized schizophrenia does not deteriorate with dopamine agonists cabergoline and bromocriptine used for ablactation. | Pharmacopsychiatry 20110301 |
| [Spontaneous ovarian hyperstimulation syndrome in a pregnancy with hypothyroidism]. | Gynecologie, obstetrique & fertilite 20110301 |
| Levodopa for restless legs syndrome. | The Cochrane database of systematic reviews 20110216 |
| Further data favouring hormonal dependency of cerebral meningiomas: evidence from a patient treated with cabergoline. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20110201 |
| [Clinical utility of cabergoline in ovarian hyperstimulation syndrome]. | Revista espanola de anestesiologia y reanimacion 20110201 |
| [Management of prolactinomas: what's new in 2010?]. | Revue medicale suisse 20110112 |
| Acromegaly: a cross-sectional analysis of the oral and maxillofacial pathologies. | Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20110101 |
| Differential induction of adenylyl cyclase supersensitivity by antiparkinson drugs acting as agonists at dopamine D1/D2/D3 receptors vs D2/D3 receptors only: parallel observations from co-transfected human and native cerebral receptors. | Neuropharmacology 20110101 |
| Cognitive enhancement by drugs in health and disease. | Trends in cognitive sciences 20110101 |
| Case report and mini literature review: anesthetic management for severe peripartum cardiomyopathy complicated with preeclampsia using sufetanil in combined spinal epidural anesthesia. | Yonsei medical journal 20110101 |
| Macroorchidism and panhypopituitarism: two different forms of presentation of FSH-secreting pituitary adenomas in adolescence. | Hormone research in paediatrics 20110101 |
| Update in pituitary 2010. | The Journal of clinical endocrinology and metabolism 20110101 |
| Panhypopituitarism secondary to a macroprolactinoma manifesting with pancytopenia: case report and literature review. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20110101 |
| Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer. | Breast cancer research : BCR 20110101 |
| Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER). | Movement disorders : official journal of the Movement Disorder Society 20110101 |
| Positive prolactin response to bromocriptine in 2 patients with cabergoline-resistant prolactinomas. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20110101 |
| Bilateral angle-closure glaucoma in a young female receiving cabergoline: a case report. | Case reports in ophthalmology 20110101 |
| Adenosine A(2A) receptors measured with [C]TMSX PET in the striata of Parkinson's disease patients. | PloS one 20110101 |
| New thoughts on thought disorders in Parkinson's disease: review of current research strategies and challenges. | Parkinson's disease 20110101 |
| Relation of subjective quality of life to motor symptom profile in Parkinson's disease. | Parkinson's disease 20110101 |
| Dopamine-induced apoptosis of lactotropes is mediated by the short isoform of D2 receptor. | PloS one 20110101 |
| Echocardiography for the detection of valvulopathy associated with the use of ergot-derived dopamine agonists in patients with Parkinson's disease. | Internal medicine (Tokyo, Japan) 20110101 |
| Aggravated stuttering following subthalamic deep brain stimulation in Parkinson's disease--two cases. | BMC neurology 20110101 |
| The dopamine agonist bromocriptine differentially affects fronto-striatal functional connectivity during working memory. | Frontiers in human neuroscience 20110101 |
| PREDICT: a method for inferring novel drug indications with application to personalized medicine. | Molecular systems biology 20110101 |
| Sleep Duration and 'on' Time during Different Periods of the Day and Night in Patients with Advanced Parkinson's Disease Receiving Adjunctive Ropinirole Prolonged Release. | Parkinson's disease 20110101 |
| Cabergoline-induced tricuspid regurgitation: Case report and review of literature. | Indian journal of endocrinology and metabolism 20110101 |
| Acromegaly associated with a symptomatic Rathke's cyst. | Indian journal of endocrinology and metabolism 20110101 |
| Impulse control disorders associated with dopaminergic medication in patients with pituitary adenomas. | Clinical neuropharmacology 20110101 |
| Bromocriptine or cabergoline induced pituitary apoplexy: Rare but life-threatening catastrophe. | Journal of human reproductive sciences 20110101 |
| Pharmacological and physiological characterization of the tremulous jaw movement model of parkinsonian tremor: potential insights into the pathophysiology of tremor. | Frontiers in systems neuroscience 20110101 |
| [Complications of treatment of prolactinoma by dopamine agonists]. | Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko 20110101 |
| Luteal and placental function in the bitch: spatio-temporal changes in prolactin receptor (PRLr) expression at dioestrus, pregnancy and normal and induced parturition. | Reproductive biology and endocrinology : RB&E 20110101 |
| Adverse drug reaction suggested by a clinical vignette. | Clinical interventions in aging 20110101 |
| Questions asked and answered in pilot and feasibility randomized controlled trials. | BMC medical research methodology 20110101 |
| Bladder, bowel, and sexual dysfunction in Parkinson's disease. | Parkinson's disease 20110101 |
| Modulation of human time processing by subthalamic deep brain stimulation. | PloS one 20110101 |
| Surgery versus watchful waiting in patients with craniofacial fibrous dysplasia--a meta-analysis. | PloS one 20110101 |
| Sporadic and genetic forms of paediatric somatotropinoma: a retrospective analysis of seven cases and a review of the literature. | Orphanet journal of rare diseases 20110101 |
| The role of inhibition in generating and controlling Parkinson's disease oscillations in the Basal Ganglia. | Frontiers in systems neuroscience 20110101 |
| Investigating the association between polymorphism of follicle-stimulating hormone receptor gene and ovarian response in controlled ovarian hyperstimulation. | Journal of human reproductive sciences 20110101 |
| Hyperprolactinemia: An often missed cause of male infertility. | Journal of human reproductive sciences 20110101 |
| Bromocriptine or cabergoline-induced cerebrospinal fluid rhinorrhea: A life-threatening complication during management of prolactinoma. | Journal of human reproductive sciences 20110101 |
| Ovarian hyperstimulation syndrome. | Journal of human reproductive sciences 20110101 |
| Immunohistochemical detection of dopamine D2 receptors in neuroendocrine tumours. | Endokrynologia Polska 20110101 |
| Constipation-predominant irritable bowel syndrome associated to hyperprolactinemia. | Case reports in gastroenterology 20110101 |
| [Inappropriate lactation syndrome in goats--case collection and experiences with mastectomy]. | Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere 20110101 |
| Fibroepithelial hyperplasia in an entire male cat: cytologic and histopathological features. | Tierarztliche Praxis. Ausgabe K, Kleintiere/Heimtiere 20110101 |
| The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer. | Neuro endocrinology letters 20110101 |
| Strategies for reducing or preventing the generation of oxidative stress. | Oxidative medicine and cellular longevity 20110101 |
| Systematic drug repositioning based on clinical side-effects. | PloS one 20110101 |
| Anaesthetic management for caesarean section in a case of previously operated with residual pituitary tumour. | Indian journal of anaesthesia 20110101 |
| [Comparative analysis of surgical and medical treatment of macroprolactinoma of different localization]. | Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko 20110101 |
| [Resistance to thyroid hormone and Hashimoto's thyroiditis]. | Cirugia y cirujanos 20110101 |
| A comprehensive study of repetitive transcranial magnetic stimulation in Parkinson's disease. | ISRN neurology 20110101 |
| [The effect of oxcarbamazepine on the clinical effectiveness of dopamine agonists in the treatment of prolactinoma]. | Wiadomosci lekarskie (Warsaw, Poland : 1960) 20110101 |
| Transformation of a microprolactinoma into a mixed growth hormone and prolactin-secreting pituitary adenoma. | Frontiers in endocrinology 20110101 |
| 'You never told me I would turn into a gambler': a first person account of dopamine agonist--induced gambling addiction in a patient with restless legs syndrome. | BMJ case reports 20110101 |
| A rare case of male breast ductal carcinoma in-situ associated with prolactinoma. | BMJ case reports 20110101 |
| [Hyperprolactinemia in mentally ill patients]. | Acta medica portuguesa 20110101 |
| Acquired resistance to cabergoline: progression from initially responsive micro to macroprolactinoma. | Pituitary 20101201 |
| Effects of cabergoline on pregnancy and embryo-fetal development: retrospective study on 103 pregnancies and a review of the literature. | Pituitary 20101201 |
| Postsynaptic nigrostriatal dopamine receptors and their role in movement regulation. | Journal of neural transmission (Vienna, Austria : 1996) 20101201 |
| Two diagnostic pitfalls mimicking a prolactin-secreting microadenoma. | The Journal of clinical endocrinology and metabolism 20101201 |
| Seniors with Parkinson's disease: initial medical treatment. | Journal of clinical neurology (Seoul, Korea) 20101201 |
| Treatment of ovarian hyperstimulation syndrome: new insights. | Acta clinica Croatica 20101201 |
| Phenotypical variability of post-partum reversible cerebral vasoconstriction syndrome. | Neurology international 20101126 |
| Effectiveness of short-term maintenance treatment with cabergoline in microadenoma-related and idiopathic hyperprolactinemia. | Archives of gynecology and obstetrics 20101101 |
| Identification and quantification of dopamine receptor 2 in human eutopic and ectopic endometrium: a novel molecular target for endometriosis therapy. | Biology of reproduction 20101101 |
| Cabergoline monotherapy in the long-term treatment of Cushing's disease. | European journal of endocrinology 20101101 |
| Physiology and pathology of ovarian hyperstimulation syndrome. | Seminars in reproductive medicine 20101101 |
| Severe tricuspid regurgitation in a patient receiving low-dose cabergoline for the treatment of acromegaly. | The Journal of heart valve disease 20101101 |
| Aggressive prolactinoma in a child related to germline mutation in the ARYL hydrocarbon receptor interacting protein (AIP) gene. | Arquivos brasileiros de endocrinologia e metabologia 20101101 |
| The acute effect of a single application of cabergoline on endogenous GH levels in patients with acromegaly on pegvisomant treatment. | Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 20101001 |
| Resolution of third nerve palsy following treatment of prolactinoma with cabergoline. | Acta neurochirurgica 20101001 |
| Pharmacological management of acromegaly: a current perspective. | Neurosurgical focus 20101001 |
| Clozapine for medication-related pathological gambling in Parkinson disease. | Movement disorders : official journal of the Movement Disorder Society 20100915 |
| Octreotide long-acting release (LAR): a review of its use in the management of acromegaly. | Drugs 20100910 |
| The risk for breast cancer is not evidently increased in women with hyperprolactinemia. | Pituitary 20100901 |
| Management of prolactinomas in Brazil: an electronic survey. | Pituitary 20100901 |
| Assessment of cardiac valve dysfunction in patients receiving cabergoline treatment for hyperprolactinaemia. | Clinical endocrinology 20100901 |
| Cabergoline therapy of paraneoplastic Cushing syndrome in children. | Pediatric blood & cancer 20100901 |
| Lipodystrophy during pegvisomant therapy: a case report and review of the literature. | Clinics (Sao Paulo, Brazil) 20100901 |
| Serotonin-2 receptor agonists as novel ocular hypotensive agents and their cellular and molecular mechanisms of action. | Current drug targets 20100801 |
| Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women. | Clinical endocrinology 20100801 |
| Cabergoline, a dopamine receptor agonist, has an antidepressant-like property and enhances brain-derived neurotrophic factor signaling. | Psychopharmacology 20100801 |
| Prolactinomas and pregnancy. | Clinical endocrinology 20100801 |
| Cystic degeneration of macroprolactinoma on long-term cabergoline. | The Journal of clinical endocrinology and metabolism 20100801 |
| Transsphenoidal treatment of secondary empty sella syndrome using low field strength intraoperative MRI: case report. | Minimally invasive neurosurgery : MIN 20100801 |
| Suppression of prolactin expression by cabergoline requires prolactin regulatory element-binding protein (PREB) in GH3 cells. | Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20100701 |
| Preventing ovarian hyperstimulation syndrome: guidance for the clinician. | Fertility and sterility 20100701 |
| Comparison of cabergoline and bromocriptine in patients with asymptomatic incidental hyperprolactinemia undergoing ICSI-ET. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20100701 |
| Transdermal rotigotine for the perioperative management of Parkinson's disease. | Journal of neural transmission (Vienna, Austria : 1996) 20100701 |
| Pseudotumor cerebri and prolactin secreting pituitary adenoma. Association or coincidence? | Neurosciences (Riyadh, Saudi Arabia) 20100701 |
| [Pituitary adenomas--where is the treatment heading at the beginning of the 21st century?]. | Vnitrni lekarstvi 20100701 |
| Changes of AMPA receptors in MPTP monkeys with levodopa-induced dyskinesias. | Neuroscience 20100602 |
| Management of acromegaly in Latin America: expert panel recommendations. | Pituitary 20100601 |
| Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing's disease. | Pituitary 20100601 |
| A double pituitary adenoma presenting as a prolactin-secreting tumor with partial response to medical therapy. Case report. | Endocrine pathology 20100601 |
| Cabergoline versus bromocriptine for symptomatic treatment of premenstrual mastalgia: a randomised, open-label study. | European journal of obstetrics, gynecology, and reproductive biology 20100601 |
| Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas. | The Journal of clinical endocrinology and metabolism 20100601 |
| Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. | The Lancet. Neurology 20100601 |
| Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease. | The New England journal of medicine 20100513 |
| Prevention of ovarian hyperstimulation syndrome in a rat model: efficacy comparison between cabergoline and meloxicam. | Acta obstetricia et gynecologica Scandinavica 20100501 |
| [Priapism secondary to treatment due to cabergoline: the first description of this association]. | Actas urologicas espanolas 20100501 |
| A comparison of bromocriptine & cabergoline on fertility outcome of hyperprolactinemic infertile women undergoing intrauterine insemination. | The Indian journal of medical research 20100501 |
| From then to now: lessons from developments in our understanding of the pituitary gland. | The Ulster medical journal 20100501 |
| Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys. | Progress in neuro-psychopharmacology & biological psychiatry 20100416 |
| Absence of major fibrotic adverse events in hyperprolactinemic patients treated with cabergoline. | European journal of endocrinology 20100401 |
| The non-ergot derived dopamine agonist quinagolide in prevention of early ovarian hyperstimulation syndrome in IVF patients: a randomized, double-blind, placebo-controlled trial. | Human reproduction (Oxford, England) 20100401 |
| Disruption of the dopamine d2 receptor impairs insulin secretion and causes glucose intolerance. | Endocrinology 20100401 |
| Pituitary gland: can prolactinomas be cured medically? | Nature reviews. Endocrinology 20100401 |
| Clinical practice. Prolactinomas. | The New England journal of medicine 20100401 |
| Efficacy of cabergoline on rapid escalation of dose in men with macroprolactinomas. | The Indian journal of medical research 20100401 |
| Clinical Review#: Potential cardiac valve effects of dopamine agonists in hyperprolactinemia. | The Journal of clinical endocrinology and metabolism 20100301 |
| Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study. | Journal of neurology 20100201 |
| Failure of cabergoline to prevent severe ovarian hyperstimulation syndrome in patients with extremely high estradiol levels. | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20100201 |
| Effect of everolimus on cell viability in nonfunctioning pituitary adenomas. | The Journal of clinical endocrinology and metabolism 20100201 |
| Tolerability and safety of ropinirole versus other dopamine agonists and levodopa in the treatment of Parkinson's disease: meta-analysis of randomized controlled trials. | Drug safety 20100201 |
| Randomized trials of dopamine agonists in restless legs syndrome: a systematic review, quality assessment, and meta-analysis. | Clinical therapeutics 20100201 |
| Decision-making during gambling: an integration of cognitive and psychobiological approaches. | Philosophical transactions of the Royal Society of London. Series B, Biological sciences 20100127 |
| BDNF levels are not related with levodopa-induced dyskinesias in MPTP monkeys. | Movement disorders : official journal of the Movement Disorder Society 20100115 |
| More than a prolactinoma. | Pituitary 20100101 |
| Gender effects on cardiac valvular function in hyperprolactinaemic patients receiving cabergoline: a retrospective study. | Clinical endocrinology 20100101 |
| Giant prolactinoma and effectiveness of medical management. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20100101 |
| Effect of apomorphine on cognitive performance and sensorimotor gating in humans. | Psychopharmacology 20100101 |
| Recurrence of hyperprolactinemia after withdrawal of dopamine agonists: systematic review and meta-analysis. | The Journal of clinical endocrinology and metabolism 20100101 |
| Prolactinomas in children and adolescents. | Endocrine development 20100101 |
| Comparative efficacy of bromocriptine, cabergoline and thyroxine in inducing oestrus in bitches. | Veterinary research communications 20100101 |
| Cabergoline therapy for prolactinomas: is valvular heart disease a real safety concern? | Expert review of cardiovascular therapy 20100101 |
| [Nelson syndrome: a rare cause of generalized hyperpigmentation of the skin]. | Actas dermo-sifiliograficas 20100101 |
| Eight-year follow-up of a child with a GH/prolactin-secreting adenoma: efficacy of pegvisomant therapy. | Hormone research in paediatrics 20100101 |
| Prolactinoma presenting as chronic anaemia with osteoporosis: a case report. | Journal of medical case reports 20100101 |
| Primary treatment of acromegaly with high-dose lanreotide: a case series. | Journal of medical case reports 20100101 |
| Can dopamine agonists reduce the incidence and severity of OHSS in IVF/ICSI treatment cycles? A systematic review and meta-analysis. | Human reproduction update 20100101 |
| Growth suppression of mouse pituitary corticotroph tumor AtT20 cells by curcumin: a model for treating Cushing's disease. | PloS one 20100101 |
| Benfluorex and unexplained valvular heart disease: a case-control study. | PloS one 20100101 |
| Achievement of fertility in an infertile man with resistant macroprolactinoma using high-dose bromocriptine and a combination of human chorionic gonadotropin and an aromatase inhibitor. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20100101 |
| Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas. | BMC endocrine disorders 20100101 |
| Intravaginal application of misoprostol improves pregnancy termination with cabergoline and alfaprostol in dogs. | Berliner und Munchener tierarztliche Wochenschrift 20100101 |
| Efficacy of cabergoline in uncured (persistent or recurrent) Cushing disease after pituitary surgical treatment with or without radiotherapy. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20100101 |
| Long-term management with octreotide or cabergoline in ectopic corticotropin hypersecretion: case report and literature review. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20100101 |
| Xanthoma disseminatum: case report and literature review. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20100101 |
| Gender differences in macroprolactinomas: study of clinical features, outcome of patients and ki-67 expression in tumor tissue. | Frontiers of hormone research 20100101 |
| Medical therapy of Cushing's disease: where are we now? | Frontiers of hormone research 20100101 |
| Optimizing acromegaly treatment. | Frontiers of hormone research 20100101 |
| Alternative strategies for the treatment of classical congenital adrenal hyperplasia: pitfalls and promises. | International journal of pediatric endocrinology 20100101 |
| Severe ovarian hyperstimulation syndrome leading to ICU admission. | Saudi journal of anaesthesia 20100101 |
| Carbidopa/levodopa/entacapone: the evidence for its place in the treatment of Parkinson's disease. | Core evidence 20100101 |
| Short- and long-term efficacy of combined cabergoline and octreotide treatment in controlling igf-I levels in acromegaly. | Neuroendocrinology 20100101 |
| Persistent CSF Rhinorrhoea, Pneumocephalus, and Recurrent Meningitis Following Misdiagnosis of Olfactory Neuroblastoma. | Case reports in medicine 20100101 |
| Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole. | Neuroendocrinology 20100101 |
| Medical treatment in Cushing's syndrome: dopamine agonists and cabergoline. | Neuroendocrinology 20100101 |
| Medical treatment of Cushing's disease: somatostatin analogues and pasireotide. | Neuroendocrinology 20100101 |
| Levodopa in the treatment of Parkinson's disease: an old drug still going strong. | Clinical interventions in aging 20100101 |
| Therapeutic interventions and adjustments in the management of Parkinson disease: role of combined carbidopa/levodopa/entacapone (Stalevo). | Neuropsychiatric disease and treatment 20100101 |
| The Di Bella Method (DBM). | Neuro endocrinology letters 20100101 |
| Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patch. | BMC neurology 20100101 |
| Treatment of Cushing disease: overview and recent findings. | Therapeutics and clinical risk management 20100101 |
| New insights in the management of antipsychotics in the treatment of schizophrenia in a patient with prolactinoma: a case report and review of the literature. | Case reports in medicine 20100101 |
| Prolactin-producing pituitary adenoma with abundant spherical amyloid deposition masquerading as extensive calcification. | Neurologia medico-chirurgica 20100101 |
| Management of acromegaly. | F1000 medicine reports 20100101 |
| Effect of bromocriptine on the severity of ovarian hyperstimulation syndrome and outcome in high responders undergoing assisted reproduction. | Journal of human reproductive sciences 20100101 |
| Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes. | Diabetes, metabolic syndrome and obesity : targets and therapy 20100101 |
| Dopamine agonist-induced antecollis in Parkinson's disease. | Movement disorders : official journal of the Movement Disorder Society 20091215 |
| [Galastop]. | Tijdschrift voor diergeneeskunde 20091215 |
| Intranasal cabergoline: pharmacokinetic and pharmacodynamic studies. | AAPS PharmSciTech 20091201 |
| Drugs in the medical treatment of Cushing's syndrome. | Expert opinion on emerging drugs 20091201 |
| Role of dopamine receptor agonists in the treatment of early Parkinson's disease. | Parkinsonism & related disorders 20091201 |
| Systematic review of the effect of dopamine receptor agonists on patient health-related quality of life. | Parkinsonism & related disorders 20091201 |
| Transdermal delivery of dopamine receptor agonists. | Parkinsonism & related disorders 20091201 |
| [Pulmonary toxicity associated with cabergoline]. | Archivos de bronconeumologia 20091101 |
| The dopamine D2 receptor antagonist sulpiride modulates striatal BOLD signal during the manipulation of information in working memory. | Psychopharmacology 20091101 |
| Non-surgical management of cystic prolactinomas. | Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20091101 |
| Parallel functional activity profiling reveals valvulopathogens are potent 5-hydroxytryptamine(2B) receptor agonists: implications for drug safety assessment. | Molecular pharmacology 20091001 |
| Efficacy and safety of cabergoline as first line treatment for invasive giant prolactinoma. | Journal of Korean medical science 20091001 |
| [Cabergoline in hyperprolactinemia and valvular heart disease]. | Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion 20091001 |
| Future treatment strategies of aggressive pituitary tumors. | Pituitary 20090901 |
| Parkinson's disease sleep scale, sleep logs, and actigraphy in the evaluation of sleep in parkinsonian patients. | Journal of neurology 20090901 |
| High dose cabergoline in management of ovarian hyperstimulation syndrome. | Fertility and sterility 20090901 |
| Treatment of ovarian hyperstimulation syndrome using a dopamine agonist and gonadotropin releasing hormone antagonist: a case series. | Fertility and sterility 20090901 |
| Drug-induced fibrotic valvular heart disease. | Lancet (London, England) 20090815 |
| An Intronic mutation is associated with prolactinoma in a young boy, decreased penetrance in his large family, and variable effects on MEN1 mRNA and protein. | Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20090801 |
| Dopamine agonists and valvular heart disease. | Current opinion in endocrinology, diabetes, and obesity 20090801 |
| [Symptomatic episodic cluster headache as the first symptom of a prolactinoma]. | Revista de neurologia 20090801 |
| Comparison of the effect of gonadotropin-releasing hormone agonist and dopamine receptor agonist on uterine myoma growth. Histologic, sonographic, and intra-operative changes. | Saudi medical journal 20090801 |
| [Recent trends in the pathophysiology and treatment of pituitary adenomas]. | Brain and nerve = Shinkei kenkyu no shinpo 20090801 |
| The older Parkinson's disease drugs pergolide and cabergoline have been linked to heart problems. Are there any new Parkinson's drugs which are safer for patients with heart risks? | Heart advisor 20090801 |
| Pathological gambling associated with cabergoline in a case of recurrent depression. | Drug discoveries & therapeutics 20090801 |
| Cabergoline decreases alcohol drinking and seeking behaviors via glial cell line-derived neurotrophic factor. | Biological psychiatry 20090715 |
| Long-term experience of pegvisomant therapy as a treatment for acromegaly. | Clinical endocrinology 20090701 |
| Recurrence of hyperprolactinemia after withdrawal of long-term cabergoline therapy. | The Journal of clinical endocrinology and metabolism 20090701 |
| Pituitary tumors. | Current treatment options in neurology 20090701 |
| Follicular dynamics, ovulation and conception rates in bitches. | Reproduction in domestic animals = Zuchthygiene 20090701 |
| Effect of an injectable cabergoline formulation on serum prolactin (PRL) and milk secretion in early postpartum Beagle bitches. | Reproduction in domestic animals = Zuchthygiene 20090701 |
| An experimental model to study resistance index and systolic/diastolic ratio of uterine arteries in adverse canine pregnancy outcome. | Reproduction in domestic animals = Zuchthygiene 20090701 |
| Influence of progesterone withdrawal on pregnancy-related parameters during post-implantation early pregnancy loss. | Reproduction in domestic animals = Zuchthygiene 20090701 |
| Morphological examination of the corpora lutea from pregnant bitches treated with different abortifacient regimes. | Reproduction in domestic animals = Zuchthygiene 20090701 |
| Effects of short-term hyper- and hypoprolactinaemia on hormones of the pituitary, gonad and -thyroid axis and on semen quality in male Beagles. | Reproduction in domestic animals = Zuchthygiene 20090701 |
| Homology modeling of adenosine A2A receptor and molecular docking for exploration of appropriate potent antagonists for treatment of Parkinson's disease. | Current aging science 20090701 |
| Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome. | Reviews in endocrine & metabolic disorders 20090601 |
| Somatostatin-dopamine ligands in the treatment of pituitary adenomas. | Reviews in endocrine & metabolic disorders 20090601 |
| [An aortic insufficiency diagnosed under cabergoline]. | Annales de cardiologie et d'angeiologie 20090601 |
| Implication of NMDA receptors in the antidyskinetic activity of cabergoline, CI-1041, and Ro 61-8048 in MPTP monkeys with levodopa-induced dyskinesias. | Journal of molecular neuroscience : MN 20090601 |
| Overnight switching from ergot-derived dopamine agonists to pramipexole in patients with Parkinson's disease: an open preliminary trial in Japan. | Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20090601 |
| Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders. | International journal of molecular sciences 20090601 |
| High dose cabergoline therapy for a resistant macroprolactinoma during pregnancy. | Clinical endocrinology 20090501 |
| Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis. | Human reproduction (Oxford, England) 20090501 |
| Characterization of resistance to the prolactin-lowering effects of cabergoline in macroprolactinomas: a study in 122 patients. | European journal of endocrinology 20090501 |
| Changes in artistic style and behaviour in Parkinson's disease: dopamine and creativity. | Journal of neurology 20090501 |
| Pegvisomant-induced cholestatic hepatitis with jaundice in a patient with Gilbert's syndrome. | European journal of endocrinology 20090501 |
| Cabergoline resistance in pediatric prolactinomas. | Journal of pediatric hematology/oncology 20090501 |
| Severe mitral valve regurgitation with fatal cardiogenic shock in a patient on long-term cabergoline treatment. | International journal of cardiology 20090417 |
| Secondary deterioration of visual field during cabergoline treatment for macroprolactinoma. | Clinical endocrinology 20090401 |
| Dopamine agonist therapy for hyperprolactinaemia and cardiac valve dysfunction; a lot done but much more to do. | Heart (British Cardiac Society) 20090401 |
| Dopamine agonists, Dopplers and doubt: cabergoline-associated cardiac valvulopathy. | Internal medicine journal 20090401 |
| Low-dose cabergoline causing valvular heart disease in a patient treated for prolactinoma. | Internal medicine journal 20090401 |
| Effects of gonadectomy on prolactin and LH secretion and the pituitary-thyroid axis in male dogs. | Theriogenology 20090315 |
| Protection against paraquat and A53T alpha-synuclein toxicity by cabergoline is partially mediated by dopamine receptors. | Journal of the neurological sciences 20090315 |
| Dopamine agonists and hyperprolactinaemia. | BMJ (Clinical research ed.) 20090303 |
| Mechanism and treatment of dropped head syndrome associated with parkinsonism. | Parkinsonism & related disorders 20090301 |
| Cabergoline: Pharmacology, ocular hypotensive studies in multiple species, and aqueous humor dynamic modulation in the Cynomolgus monkey eyes. | Experimental eye research 20090301 |
| Involvement of the subthalamic nucleus in engagement with behaviourally relevant stimuli. | The European journal of neuroscience 20090301 |
| Giant prolactinoma. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20090301 |
| Hair loss in women. | Seminars in cutaneous medicine and surgery 20090301 |
| B-type natriuretic peptide and cardiovalvulopathy in Parkinson disease with dopamine agonist. | Neurology 20090217 |
| Bromocriptine use and the risk of valvular heart disease. | Movement disorders : official journal of the Movement Disorder Society 20090215 |
| Chronic cluster-like headache secondary to prolactinoma: uncommon cephalalgia in association with brain tumors. | Journal of pain and symptom management 20090201 |
| High risk factors for valvular heart disease from dopamine agonists in patients with Parkinson's disease. | Journal of neural transmission (Vienna, Austria : 1996) 20090201 |
| Risk of valvular heart disease associated with the use of dopamine agonists in Parkinson's disease: a systematic review. | Journal of neural transmission (Vienna, Austria : 1996) 20090201 |
| Effective control of catatonia in Parkinson's disease by electroconvulsive therapy: a case report. | European journal of neurology 20090201 |
| Rapid left ventricular recovery after cabergoline treatment in a patient with peripartum cardiomyopathy. | European journal of heart failure 20090201 |
| The effects of treating male hypogonadism on couples' sexual desire and function. | The journal of sexual medicine 20090201 |
| [Pleural effusion and pulmonary hypertension in a patient with Parkinson disease treated with cabergoline]. | Archivos de bronconeumologia 20090201 |
| McCune-Albright syndrome and acromegaly: hormonal control with use of cabergoline and long-acting somatostatin--case report. | Arquivos brasileiros de endocrinologia e metabologia 20090201 |
| Pathological gambling and hypersexuality in cabergoline-treated prolactinoma. | The Medical journal of Australia 20090119 |
| Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists. | Movement disorders : official journal of the Movement Disorder Society 20090115 |
| Long-term cabergoline therapy is not associated with valvular heart disease in patients with prolactinomas. | Pituitary 20090101 |
| Insulin-like growth factor-1 is essential to the increased mortality caused by excess growth hormone: a case of thyroid cancer and non-Hodgkin's lymphoma in a patient with pituitary acromegaly. | Medical oncology (Northwood, London, England) 20090101 |
| Clinical profile and long term follow up of children and adolescents with prolactinomas. | Pituitary 20090101 |
| The medical treatment of Cushing's disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery. | The Journal of clinical endocrinology and metabolism 20090101 |
| Management of aggressive pituitary adenomas: current treatment strategies. | Pituitary 20090101 |
| Effect of cabergoline on parkinsonian tremor assessed by long-term actigraphy. | European neurology 20090101 |
| Valvular heart disease and the use of cabergoline for the treatment of prolactinoma. | Clinical endocrinology 20090101 |
| Invasive giant prolactinoma with loss of therapeutic response to cabergoline: expression of angiogenic markers. | Endocrine pathology 20090101 |
| Transcranial magnetic stimulation, synaptic plasticity and network oscillations. | Journal of neuroengineering and rehabilitation 20090101 |
| [Magnetic resonance for evaluating the response to treatment for ovarian hyperstimulation syndrome: comparison of pharmokinetic models.]. | Radiologia 20090101 |
| How to avoid ovarian hyperstimulation syndrome: a new indication for dopamine agonists. | Reproductive biomedicine online 20090101 |
| Optimizing medical therapy of acromegaly: beneficial effects of cabergoline in patients uncontrolled with long-acting release octreotide. | Neuroendocrinology 20090101 |
| A review of ropinirole prolonged release in Parkinson's disease. | Clinical interventions in aging 20090101 |
| Dopamine Agonists and their risk to induce psychotic episodes in Parkinson's disease: a case-control study. | BMC neurology 20090101 |
| Restless legs syndrome: differential diagnosis and management with rotigotine. | Neuropsychiatric disease and treatment 20090101 |
| Electrode displacement after intracerebral hematoma as a complication of a deep brain stimulation procedure. | Neuropsychiatric disease and treatment 20090101 |
| A randomized controlled trial of quetiapine for psychosis in Parkinson's disease. | Neuropsychiatric disease and treatment 20090101 |
| [Selection of management tactics in treatment of giant prolactin-secreting pituitary adenomas]. | Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko 20090101 |
| Pleuropulmonary Toxicity of Another Anti-Parkinson's Drug: Cabergoline. | The open respiratory medicine journal 20090101 |
| [Usefulness of cabergoline in patients with prolactinemia and resistant or intolerant to bromocriptine]. | Cirugia y cirujanos 20090101 |
| Restless legs syndrome: differential diagnosis and management with pramipexole. | Clinical interventions in aging 20090101 |
| Hyperthyroidism unmasked several years after the medical and radiosurgical treatment of an invasive macroprolactinoma inducing hypopituitarism: a case report. | Cases journal 20090101 |
| Cardiac surgery in a patient with retroperitoneal fibrosis and heart valvulopathy, both due to pergolide medication for Parkinson's disease. | Journal of cardiothoracic surgery 20090101 |
| Pneumocephalus during cabergoline treatment of an invasive macroprolactinoma. | Acta clinica Belgica 20090101 |
| [Treatment of macroprolactinoma with cabergoline during pregnancy]. | Revista medica del Instituto Mexicano del Seguro Social 20090101 |
| Further evidence for aberrant prefrontal salience coding in schizophrenia. | Frontiers in behavioral neuroscience 20090101 |
| Medical treatment of Cushing's disease: Overview and recent findings. | International journal of general medicine 20090101 |
| [Application of Pfizer drugs in the obstetrics and gynecology practice]. | Akusherstvo i ginekologiia 20090101 |
| Ovarian hyperstimulation syndrome: current views on pathophysiology, risk factors, prevention, and management. | Journal of experimental & clinical assisted reproduction 20090101 |
| New treatment guidelines on Cushing's disease. | F1000 medicine reports 20090101 |
| Spontaneous cerebrospinal fluid rhinorrhoea as the presenting feature of an invasive macroprolactinoma. | BMJ case reports 20090101 |
| Pramipexole as a possible cause of the syndrome of inappropriate antidiuresis. | BMJ case reports 20090101 |
| Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. | Movement disorders : official journal of the Movement Disorder Society 20081215 |
| [Hyperprolactinemia in a man's world]. | Praxis 20081203 |
| Treatment with low doses of cabergoline is not associated with increased prevalence of cardiac valve regurgitation in patients with hyperprolactinaemia. | International journal of clinical practice 20081201 |
| Cabergoline and pramipexole fail to modify already established dyskinesias in an animal model of parkinsonism. | Behavioural brain research 20081201 |
| Prospective study of high-dose cabergoline treatment of prolactinomas in 150 patients. | The Journal of clinical endocrinology and metabolism 20081201 |
| The cabergoline-resistant prolactinoma patient: new challenges. | The Journal of clinical endocrinology and metabolism 20081201 |
| Conduct disorder in an adolescent girl treated with an insulin-sensitizing agent. | Psychiatry and clinical neurosciences 20081201 |
| Cabergoline reduces the early onset of ovarian hyperstimulation syndrome: a prospective randomized study. | Reproductive biomedicine online 20081201 |
| [Progress in gynecological endocrinology]. | Ginekologia polska 20081201 |
| Cabergoline therapy and the risk of cardiac valve regurgitation in patients with hyperprolactinemia: a meta-analysis from clinical studies. | Journal of endocrinological investigation 20081201 |
| Clinical use of cabergoline as primary and adjunctive treatment for acromegaly. | European journal of endocrinology 20081101 |
| Pituitary apoplexy within a macroprolactinoma. | Nature clinical practice. Endocrinology & metabolism 20081101 |
| Case report: Unusual orbital invasion by a giant prolactinoma. | The British journal of radiology 20081101 |
| Body fat in men with prolactinoma. | Journal of endocrinological investigation 20081101 |
| Dopamine D2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas. | The pharmacogenomics journal 20081001 |
| Low dose cabergoline for hyperprolactinaemia is not associated with clinically significant valvular heart disease. | European journal of endocrinology 20081001 |
| Suppression of beta oscillations in the subthalamic nucleus following cortical stimulation in humans. | The European journal of neuroscience 20081001 |
| Increased prevalence of tricuspid regurgitation in patients with prolactinomas chronically treated with cabergoline. | The Journal of clinical endocrinology and metabolism 20081001 |
| Cabergoline and cardiac valve disease in prolactinoma patients: additional studies during long-term treatment are required. | European journal of endocrinology 20081001 |
| Aortic valve calcification and mild tricuspid regurgitation but no clinical heart disease after 8 years of dopamine agonist therapy for prolactinoma. | The Journal of clinical endocrinology and metabolism 20080901 |
| [New medical treatments in pituitary adenomas]. | Annales d'endocrinologie 20080901 |
| Prevalence of valvular heart disease in a cohort of patients taking cabergoline for management of hyperprolactinemia. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20080901 |
| Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans. | Current neuropharmacology 20080901 |
| Therapeutic options in the management of acromegaly: focus on lanreotide Autogel. | Biologics : targets & therapy 20080901 |
| Cushing's disease in dogs: cabergoline treatment. | Research in veterinary science 20080801 |
| Effect of long-term cabergoline therapy on the immunological pattern and pituitary function of patients with idiopathic hyperprolactinaemia positive for antipituitary antibodies. | Clinical endocrinology 20080801 |
| Parkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognition. | Brain : a journal of neurology 20080801 |
| Beneficial effect of pramipexole for motor function and depression in Parkinson's disease. | Neuropsychiatric disease and treatment 20080801 |
| Current approaches to the treatment of Parkinson's disease. | Neuropsychiatric disease and treatment 20080801 |
| Augmentation in restless legs syndrome is associated with low ferritin. | Sleep medicine 20080701 |
| Case study of a 15-year-old boy with McCune-Albright syndrome combined with pituitary gigantism: effect of octreotide-long acting release (LAR) and cabergoline therapy. | Endocrine journal 20080701 |
| Cabergoline and the risk of valvular lesions in endocrine disease. | European journal of endocrinology 20080701 |
| Sleep-wake cycle and effects of cabergoline monotherapy in de novo Parkinson's disease patients. An ambulatory polysomnographic study. | Journal of neurology 20080701 |
| [Two cases of patients with Parkinson's disease developing valvular heart disease while taking cabergoline]. | Rinsho shinkeigaku = Clinical neurology 20080701 |
| Role of D1 and D2 receptors in the regulation of voluntary movements. | Bulletin of experimental biology and medicine 20080701 |
| Pharmacological treatment of hypercortisolism. | Current opinion in endocrinology, diabetes, and obesity 20080601 |
| Nephrotic-range proteinuria in a patient with a giant prolactinoma. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20080601 |
| TSH-secreting adenoma improved with cabergoline. | Annales d'endocrinologie 20080601 |
| Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study. | Endocrine-related cancer 20080601 |
| The frequency of cardiac valvular regurgitation in Parkinson's disease. | Movement disorders : official journal of the Movement Disorder Society 20080515 |
| Relevance of coexpression of somatostatin and dopamine D2 receptors in pituitary adenomas. | Molecular and cellular endocrinology 20080514 |
| Somatostatinergic ligands in dopamine-sensitive and -resistant prolactinomas. | European journal of endocrinology 20080501 |
| Pituitary-targeted medical therapy of Cushing's disease. | Expert opinion on investigational drugs 20080501 |
| Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients. | Journal of endocrinological investigation 20080501 |
| Emotional speech in Parkinson's disease. | Movement disorders : official journal of the Movement Disorder Society 20080430 |
| Effect of co-administration of a serotonin-noradrenaline reuptake inhibitor and a dopamine agonist on extracellular monoamine concentrations in rats. | European journal of pharmacology 20080428 |
| A case of constrictive pericarditis during cabergoline treatment for hyperprolactinaemia. | European journal of endocrinology 20080401 |
| Update on the use of pramipexole in the treatment of Parkinson's disease. | Neuropsychiatric disease and treatment 20080401 |
| [Some issues in the diagnosis and treatment of hyperprolactinemia]. | Zhonghua fu chan ke za zhi 20080401 |
| [Sexual dysfunctions induced by antidepressants and antipsychotics]. | Revue medicale suisse 20080326 |
| Management of acromegaly: is there a role for primary medical therapy? | Reviews in endocrine & metabolic disorders 20080301 |
| [Recurrent nerve paralysis and pleural effusion due to cabergoline]. | Revista de neurologia 20080301 |
| Growth hormone producing prolactinoma in juvenile cystinosis: a simple coincidence? | Pediatric nephrology (Berlin, Germany) 20080201 |
| Normalization of GABAA receptor specific binding in the substantia nigra reticulata and the prevention of L-dopa-induced dyskinesias in MPTP parkinsonian monkeys. | Synapse (New York, N.Y.) 20080201 |
| Basal ganglia group II metabotropic glutamate receptors specific binding in non-human primate model of L-Dopa-induced dyskinesias. | Neuropharmacology 20080201 |
| Restless legs syndrome in older adults. | Clinics in geriatric medicine 20080201 |
| Absence of hypogonadism in a male patient with a giant prolactinoma: a clinical paradox. | Annales d'endocrinologie 20080201 |
| Cabergoline-associated erythema nodosum. | The Annals of pharmacotherapy 20080201 |
| Burden of cardiovascular diseases in elderly with Parkinson's disease who start a dopamine agonist agent. | Journal of the American Geriatrics Society 20080201 |
| Remission of acromegaly following long-term therapy with cabergoline: report of two cases. | Pituitary 20080101 |
| Pituitary apoplexy during treatment of cystic macroprolactinomas with cabergoline. | Pituitary 20080101 |
| Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study. | Clinical endocrinology 20080101 |
| A case of macroprolactinoma encasing an internal carotid artery aneurysm, presenting as pituitary apoplexy. | Pituitary 20080101 |
| Remarkable effects of cabergoline in a patient with huge prolactinoma resistant to high-dose bromocriptine: case report. | Surgical neurology 20080101 |
| Acromegaly and anaplastic astrocytoma: coincidence or pathophysiological relation? | Pituitary 20080101 |
| Heart valve disease associated with treatment with ergot-derived dopamine agonists: a clinical and echocardiographic study of patients with Parkinson's disease. | Journal of internal medicine 20080101 |
| Tramadol and severe hypertension during anesthesia. | Journal of neurosurgical anesthesiology 20080101 |
| Pramipexole safely replaces ergot dopamine agonists with either rapid or slow switching. | The Journal of international medical research 20080101 |
| Apoptosis of lactotrophs induced by D2 receptor activation is estrogen dependent. | Neuroendocrinology 20080101 |
| Quality of life in women with microprolactinoma treated with dopamine agonists. | Pituitary 20080101 |
| Aortic regurgitation associated with cabergoline therapy. | British journal of hospital medicine (London, England : 2005) 20080101 |
| Cabergoline for suppression of puerperal lactation in a prevention of mother-to-child HIV-transmission programme in rural Malawi. | Tropical doctor 20080101 |
| Conversion from dopamine agonists to cabergoline: an open-label trial in 128 patients with advanced Parkinson disease. | Clinical neuropharmacology 20080101 |
| Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome. | Human reproduction update 20080101 |
| McCune-Albright syndrome. | Orphanet journal of rare diseases 20080101 |
| Remission in Cushing disease with cabergoline. | Annals of Saudi medicine 20080101 |
| Acromegaly. | Orphanet journal of rare diseases 20080101 |
| Cabergoline-induced psychotic exacerbation in schizophrenic patients. | General hospital psychiatry 20080101 |
| Paget's disease of the skull causing hyperprolactinemia and erectile dysfunction: a case report. | Journal of medical case reports 20080101 |
| Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity. | Breast cancer research : BCR 20080101 |
| Misdiagnosis due to the hook effect in prolactin assay. | Medical principles and practice : international journal of the Kuwait University, Health Science Centre 20080101 |
| Receptor-binding and pharmacokinetic properties of dopaminergic agonists. | Current topics in medicinal chemistry 20080101 |
| Cost effectiveness of pharmacotherapies in early Parkinson's disease. | CNS drugs 20080101 |
| [Clinical presentation, diagnostics and results of primary conservative treatment of large and giant prolactin-secreting pituitary adenomas]. | Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko 20080101 |
| Hyperprolactinaemia with amisulpride. | Indian journal of psychiatry 20080101 |
| The treatment of Parkinson's disease with dopamine agonists. | GMS health technology assessment 20080101 |
| [Cardiac valvulopathy and dopamine agonist]. | Neurologia (Barcelona, Spain) 20071201 |
| Antiparkinson therapeutic potencies correlate with their affinities at dopamine D2(High) receptors. | Synapse (New York, N.Y.) 20071201 |
| [Aortic insufficiency under weak doses of cabergoline for non-tumoral hyperprolactinemia]. | Annales d'endocrinologie 20071201 |
| Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilot study. | Human reproduction (Oxford, England) 20071201 |
| Dopamine gene predicts the brain's response to dopaminergic drug. | The European journal of neuroscience 20071201 |
| Influence of cabergoline on motor excitability in patients with restless legs syndrome. | Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society 20071201 |
| Pharmacologic prevention of aspiration pneumonia: a systematic review. | The American journal of geriatric pharmacotherapy 20071201 |
| [Nelson's syndrome management: current knowledge]. | La Revue de medecine interne 20071101 |
| Meta-analysis of heart valve abnormalities in Parkinson's disease patients treated with dopamine agonists. | Movement disorders : official journal of the Movement Disorder Society 20071015 |
| [Association between amytrophic lateral sclerosis and Parkinson's disease]. | Medicina clinica 20071006 |
| Cabergoline treatment of pregnant women with macroprolactinomas. | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20071001 |
| Follicular development and plasma concentrations of LH and prolactin in anestrous female dogs treated with the dopamine agonist cabergoline. | Theriogenology 20071001 |
| Repeated induction of abortion in bitches and the effect on plasma concentrations of relaxin, progesterone and estradiol-17beta. | Theriogenology 20071001 |
| [Mitral valve replacement for cabergoline-related severe mitral regurgitation]. | Kyobu geka. The Japanese journal of thoracic surgery 20071001 |
| Role of dopamine agonists in Parkinson's disease: an update. | Expert review of neurotherapeutics 20071001 |
| [Treatment with cabergoline in Parkinson disease can cause heart damage. Continuous treatment requires clinical and echocardiographic check ups]. | Lakartidningen 20071001 |
| Pharmacological causes of hyperprolactinemia. | Therapeutics and clinical risk management 20071001 |
| The effects of a low dose of cabergoline on induction of estrus and pregnancy rates in anestrous bitches. | Animal reproduction science 20070901 |
| Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapy. | Clinical endocrinology 20070901 |
| Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease. | The Lancet. Neurology 20070901 |
| Restless legs syndrome and periodic limb movements during sleep: diagnosis and treatment. | The neurologist 20070901 |
| Evolution of a prolactin-secreting pituitary microadenoma into a fatal carcinoma: a case report. | Minerva endocrinologica 20070901 |
| [Early pleuropulmonary toxicity associated with cabergoline, an antiparkinsonian drug]. | Archivos de bronconeumologia 20070901 |
| Nonsurgical treatment of male infertility: specific and empiric therapy. | Biologics : targets & therapy 20070901 |
| Efficacy and tolerability of Entacapone versus Cabergoline in parkinsonian patients suffering from wearing-off. | Movement disorders : official journal of the Movement Disorder Society 20070815 |
| Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction. | The Journal of clinical endocrinology and metabolism 20070801 |
| Long-term (up to 18 years) effects on GH/IGF-1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH-secreting pituitary adenoma responsive to SSTa. | Clinical endocrinology 20070801 |
| Dopaminergic treatment of nonfunctioning pituitary adenomas. | Nature clinical practice. Endocrinology & metabolism 20070801 |
| Estrus induction and synchronization in canids and felids. | Theriogenology 20070801 |
| An important new adaption of a specific drug? | Fertility and sterility 20070801 |
| Editorial: Preventing ovarian hyperstimulation syndrome. | The Journal of clinical endocrinology and metabolism 20070801 |
| Dopamine agonists and cardiac valvulopathy in Parkinson disease: a case-control study. | Neurology 20070703 |
| Author's reply: the influences of hyperprolactinaemia and obesity on cardiovascular risk markers: effects of cabergoline therapy. | Clinical endocrinology 20070701 |
| Long-term management in five cases of TSH-secreting pituitary adenomas: a single center study and review of the literature. | European journal of endocrinology 20070701 |
| Di(2-ethylhexyl) phthalate metabolites may alter thyroid hormone levels in men. | Environmental health perspectives 20070701 |
| Drug treatment of hyperprolactinemia. | Annales d'endocrinologie 20070601 |
| Prolactinoma and estrogens: pregnancy, contraception and hormonal replacement therapy. | Annales d'endocrinologie 20070601 |
| Antipituitary antibodies in idiopathic hyperprolactinemic patients. | Annals of the New York Academy of Sciences 20070601 |
| Rasagiline - a novel MAO B inhibitor in Parkinson's disease therapy. | Therapeutics and clinical risk management 20070601 |
| Continuous levodopa for advanced Parkinson's disease. | Neuropsychiatric disease and treatment 20070601 |
| Assessment of valvulopathy in Parkinson's disease patients on pergolide and/or cabergoline. | Clinical neurology and neurosurgery 20070501 |
| Rapid pituitary tumor shrinkage with dissociation between antiproliferative and antisecretory effects of a long-acting octreotide in an acromegalic patient. | The Journal of clinical endocrinology and metabolism 20070501 |
| Growth hormone excess with onset in adolescence: clinical appearance and long-term treatment outcome. | Clinical endocrinology 20070501 |
| Polycystic ovary syndrome and hyperprolactinemia are distinct entities. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20070501 |
| Dopamine agonists and valvular heart disease. | The New England journal of medicine 20070419 |
| Dopamine agonists and valvular heart disease. | The New England journal of medicine 20070419 |
| Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: results from a multi-center, randomized, active controlled trial. | Movement disorders : official journal of the Movement Disorder Society 20070415 |
| Parkinson's drugs linked to heart valve trouble. | Harvard heart letter : from Harvard Medical School 20070401 |
| Spectrophotometric determination of dopaminergic drugs used for Parkinson's disease, cabergoline and ropinirole, in pharmaceutical preparations. | Chemical & pharmaceutical bulletin 20070401 |
| Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours. | European journal of endocrinology 20070401 |
| Radioiodine uptake in non-lactating mammary glands: evidence for a causative role of hyperprolactinemia. | Thyroid : official journal of the American Thyroid Association 20070401 |
| Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis. | Movement disorders : official journal of the Movement Disorder Society 20070315 |
| Treatment of spontaneous pyometra in 22 bitches with a combination of cabergoline and cloprostenol. | The Veterinary record 20070303 |
| Comparison of the effect of gonadotropin-releasing hormone analog (Diphereline) and Cabergoline (Dostinex) treatment on uterine myoma regression. | Saudi medical journal 20070301 |
| Successful monotherapy treatment with aripiprazole in a patient with schizophrenia and prolactinoma. | Journal of psychiatric practice 20070301 |
| A case of McCune-Albright syndrome with associated multiple endocrinopathies. | The Korean journal of internal medicine 20070301 |
| TMS-assisted neurophysiological profiling of the dopamine receptor agonist cabergoline in human motor cortex. | Journal of neural transmission (Vienna, Austria : 1996) 20070201 |
| Effectiveness of long-term cabergoline treatment for giant prolactinoma: study of 12 men. | European journal of endocrinology 20070201 |
| Parathyroid carcinoma in multiple endocrine neoplasia type 1 (MEN1) syndrome: two case reports of an unrecognised entity. | Journal of endocrinological investigation 20070201 |
| Pathological gambling and dopamine agonists: A phenotype? | Neuropsychiatric disease and treatment 20070201 |
| Japanese experience with milnacipran, the first serotonin and norepinephrine reuptake inhibitor in Japan. | Neuropsychiatric disease and treatment 20070201 |
| Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: a reader-blinded monocenter echocardiography study. | Movement disorders : official journal of the Movement Disorder Society 20070115 |
| Drugs and valvular heart disease. | The New England journal of medicine 20070104 |
| Dopamine agonists and the risk of cardiac-valve regurgitation. | The New England journal of medicine 20070104 |
| Valvular heart disease and the use of dopamine agonists for Parkinson's disease. | The New England journal of medicine 20070104 |
| Mitral heart disease due to cabergoline. | International journal of cardiology 20070102 |
| Cabergoline treatment in men with psychogenic erectile dysfunction: a randomized, double-blind, placebo-controlled study. | International journal of impotence research 20070101 |
| Dopamine receptor expression and function in corticotroph ectopic tumors. | The Journal of clinical endocrinology and metabolism 20070101 |
| Unusual late development of dopamine agonist resistance in two women with hyperprolactinaemia associated with transition from micro to macroadenoma. | Clinical endocrinology 20070101 |
| Reduced growth of beard as the only diagnostic sign in a patient with macroprolactinoma. | Journal of the European Academy of Dermatology and Venereology : JEADV 20070101 |
| SUNCT syndrome in a patient with prolactinoma and cabergoline-induced attacks. | Cephalalgia : an international journal of headache 20070101 |
| Clinical presentation and response to therapy in patients with massive prolactin hypersecretion. | Pituitary 20070101 |
| [Comparative evaluation of effectiveness of treatment of hyperprolactinemia]. | Georgian medical news 20070101 |
| Caveolin-1 sensitizes rat pituitary adenoma GH3 cells to bromocriptine induced apoptosis. | Cancer cell international 20070101 |
| Ovulation disorders: part I anovulation associated with estrogen deficiency. | Clinical and experimental obstetrics & gynecology 20070101 |
| Prolactin and autoimmune diseases in humans. | Acta bio-medica : Atenei Parmensis 20070101 |
| Pergolide and cabergoline were associated with increased risk for newly diagnosed cardiac valve regurgitation. | ACP journal club 20070101 |
| Pergolide and cabergoline increased risk for valvular heart disease in Parkinson disease. | ACP journal club 20070101 |
| State of the art in restless legs syndrome therapy: practice recommendations for treating restless legs syndrome. | Movement disorders : official journal of the Movement Disorder Society 20070101 |
| Effect of dopamine agonists on prolactinomas and normal pituitary assessed by dynamic contrast enhanced magnetic resonance imaging (DCE-MRI). | Pituitary 20070101 |
| [Risperidone-induced symptomatic hyperprolactinemia in youth with schizophrenia: efficacy and tolerability of cabergoline treatment]. | La Clinica terapeutica 20070101 |
| Management of type 2 diabetes mellitus associated with pituitary gigantism. | Pituitary 20070101 |
| Medical management of levodopa-associated motor complications in patients with Parkinson's disease. | CNS drugs 20070101 |
| Substantial shrinkage of adenomas cosecreting growth hormone and prolactin with use of cabergoline therapy. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20070101 |
| Overnight switch from oral dopaminergic agonists to transdermal rotigotine patch in subjects with Parkinson disease. | Clinical neuropharmacology 20070101 |
| [Choosing a dopamine agonist in Parkinson's disease]. | Neurologia i neurochirurgia polska 20070101 |
| [Dopamine agonists in the treatment of motor complications in advanced Parkinson's disease]. | Neurologia i neurochirurgia polska 20070101 |
| Pathological gambling associated with cabergoline therapy in a patient with a pituitary prolactinoma. | The Journal of neuropsychiatry and clinical neurosciences 20070101 |
| [Some possibilities for application of 'Pfizer' medicines--Prostin 15m, Prostin E2, Prepidil gel, Dostinex, Synarel--in the obstetrician practice]. | Akusherstvo i ginekologiia 20070101 |
| [Simultaneous defect of visual fields and loss of libido--a coincidence?]. | Praxis 20061206 |
| Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson's disease: an open label 24-hour polysomnographic study. | Journal of neural transmission (Vienna, Austria : 1996) 20061201 |
| [Treatment of pituitary gland hyperfunction: from acromegaly to prolactinoma]. | Der Internist 20061201 |
| Striking differences of action of lisuride stereoisomers at histamine H1 receptors. | Naunyn-Schmiedeberg's archives of pharmacology 20061201 |
| The influences of hyperprolactinaemia and obesity on cardiovascular risk markers: effects of cabergoline therapy. | Clinical endocrinology 20061201 |
| Presentation of a functional pituitary adenoma as a significant decrease in prostate-specific antigen level in a patient followed for prostate cancer. | The Canadian journal of urology 20061201 |
| [Predictive value of the Knosp classification in grading the surgical resection of invasive pituitary macroadenomas. A prospective study of 23 cases]. | Neurocirugia (Asturias, Spain) 20061201 |
| Cerebrospinal fluid leakage as complication of treatment with cabergoline for macroprolactinomas. | Journal of endocrinological investigation 20061201 |
| First-line therapy of acromegaly: a statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group. | Journal of endocrinological investigation 20061201 |
| Resolution of a hyperprolactinemia in a western lowland gorilla (Gorilla gorilla gorilla). | Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians 20061201 |
| Nanomedicines in the treatment of acromegaly: focus on pegvisomant. | International journal of nanomedicine 20061201 |
| Sildenafil in the treatment of erectile dysfunction: an overview of the clinical evidence. | Clinical interventions in aging 20061201 |
| Restless leg syndrome: is it a real problem? | Therapeutics and clinical risk management 20061201 |
| Restless legs is a medical disorder and can be treated. | Neuropsychiatric disease and treatment 20061201 |
| Ropinirole for the treatment of restless legs syndrome. | Neuropsychiatric disease and treatment 20061201 |
| Rotigotine transdermal system: a short review. | Neuropsychiatric disease and treatment 20061201 |
| Effects of restless legs syndrome (RLS) on sleep. | Neuropsychiatric disease and treatment 20061201 |
| Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model. | Endocrinology 20061101 |
| Timing and potential role of diagnostic I-123 scintigraphy in assessing radioiodine breast uptake before ablation in postpartum women with thyroid cancer: a case series. | Clinical nuclear medicine 20061101 |
| Dopamine agonist therapy of clinically non-functioning pituitary macroadenomas. Is there a role for 123I-epidepride dopamine D2 receptor imaging? | European journal of endocrinology 20061101 |
| Macroprolactinemia in a patient with infertility and hyperprolactinemia. | Southern medical journal 20061101 |
| Management of sleep problems in Parkinson's disease. | Journal of the neurological sciences 20061025 |
| Dopamine agonists and cardiac valvulopathy in Parkinson disease: a case-control study. | Neurology 20061010 |
| Combination dopamine agonist and prostaglandin agonist treatment of cystic endometrial hyperplasia-pyometra complex in the bitch. | Theriogenology 20061001 |
| Morphology of canine placental sites after induced embryonic or fetal death. | Theriogenology 20061001 |
| Dopamine agonists, anti-progestins, anti-androgens, long-term-release GnRH agonists and anti-estrogens in canine reproduction: a review. | Theriogenology 20061001 |
| Cabergoline reverses cortical hyperexcitability in patients with restless legs syndrome. | Acta neurologica Scandinavica 20061001 |
| EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep. | European journal of neurology 20061001 |
| Management of resistant prolactinomas. | Nature clinical practice. Endocrinology & metabolism 20061001 |
| Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR). | Neurology 20060926 |
| A systematic review on clinical management of antipsychotic-induced sexual dysfunction in schizophrenia. | Sao Paulo medical journal = Revista paulista de medicina 20060907 |
| The effect of administering a dopamine agonist (Cabergoline) on follicular and luteal development during pro-estrus and estrus in the female greyhound. | Theriogenology 20060901 |
| Efficacy of lanreotide Autogel administered every 4-8 weeks in patients with acromegaly previously responsive to lanreotide microparticles 30 mg: a phase III trial. | Clinical endocrinology 20060901 |
| Effectiveness of treating ovarian hyperstimulation syndrome with cabergoline in two patients with gonadotropin-producing pituitary adenomas. | Fertility and sterility 20060901 |
| [Treatment of Parkinson disease: therapeutic reserve of the dopaminergic agonist]. | Neurologia (Barcelona, Spain) 20060901 |
| Prolactin-secreting tumors: what's new? | Expert review of anticancer therapy 20060901 |
| Hormonal control of inhibin B in men. | Journal of endocrinological investigation 20060901 |
| [Use of cabergoline in persisting Cushing's disease]. | Annales d'endocrinologie 20060901 |
| Modification of practice-dependent plasticity in human motor cortex by neuromodulators. | Cerebral cortex (New York, N.Y. : 1991) 20060801 |
| Giant invasive pituitary prolactinoma with falsely low serum prolactin: the significance of 'hook effect'. | Journal of neuro-oncology 20060801 |
| Valvular heart disease in Parkinson's disease vs. controls: An echocardiographic study. | Movement disorders : official journal of the Movement Disorder Society 20060801 |
| Documented and anecdotal effects of certain pharmaceutical agents used to enhance semen quality in the dog. | Theriogenology 20060801 |
| Anoestrus in the dog: a fascinating story. | Reproduction in domestic animals = Zuchthygiene 20060801 |
| A review of the receptor-binding and pharmacokinetic properties of dopamine agonists. | Clinical therapeutics 20060801 |
| Newer options in the management of acromegaly. | Internal medicine journal 20060701 |
| Acromegaly with moderate hyperprolactinemia caused by an intrasellar macroadenoma. | Nature clinical practice. Endocrinology & metabolism 20060701 |
| [Constrictive pericarditis caused by carbergoline]. | Ugeskrift for laeger 20060626 |
| Chronic paroxysmal hemicrania in a patient with a macroprolactinoma. | Cephalalgia : an international journal of headache 20060601 |
| A mechanistic account of striatal dopamine function in human cognition: psychopharmacological studies with cabergoline and haloperidol. | Behavioral neuroscience 20060601 |
| [Case of juvenile parkinsonism in pregnancy]. | Rinsho shinkeigaku = Clinical neurology 20060601 |
| Restless legs syndrome: diagnosis and review of management options. | Neuropsychiatric disease and treatment 20060601 |
| Effects of the dopamine agonist cabergoline on the pulsatile and TRH-induced secretion of prolactin, LH, and testosterone in male beagle dogs. | Theriogenology 20060501 |
| Suppression of prolactin does not reduce infant care by parentally experienced male common marmosets (Callithrix jacchus). | Hormones and behavior 20060501 |
| Postischemic delayed Holmes' tremor responding to low-dose cabergoline. | Movement disorders : official journal of the Movement Disorder Society 20060501 |
| Cabergoline in Huntington's disease: the first case report. | Acta neurologica Scandinavica 20060501 |
| Dramatic remission of treatment-resistant depression after the cessation of tricyclic antidepressants. | Pharmacopsychiatry 20060501 |
| McCune-Albright syndrome: growth hormone and prolactin hypersecretion. | Journal of pediatric endocrinology & metabolism : JPEM 20060501 |
| Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. | Neurology 20060411 |
| Psychiatric sequelae of Parkinson disease: a case report. | European psychiatry : the journal of the Association of European Psychiatrists 20060401 |
| Dopaminergic drugs may counteract behavioral and biochemical changes induced by models of brain injury. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20060401 |
| Current treatment issues in female hyperprolactinaemia. | European journal of obstetrics, gynecology, and reproductive biology 20060401 |
| High prolactin levels as a worsening factor for migraine. | The journal of headache and pain 20060401 |
| The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy. | Clinical endocrinology 20060401 |
| Influence of parasellar extension of macroprolactinomas defined by magnetic resonance imaging on their responsiveness to dopamine agonist therapy. | Clinical endocrinology 20060401 |
| Cabergoline scavenges peroxynitrite enhanced by L-DOPA therapy in patients with Parkinson's disease. | European journal of neurology 20060401 |
| [Acromegaly: multifaceted clinical presentation of a rare disease of the elderly. Report of two cases with long-term follow-up]. | Recenti progressi in medicina 20060401 |
| Drug insight: Cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women. | Nature clinical practice. Endocrinology & metabolism 20060401 |
| The treatment with cabergoline for 24 month normalizes the quality of seminal fluid in hyperprolactinaemic males. | Clinical endocrinology 20060301 |
| Headache induced by dopamine agonists prescribed for prolactinoma: think SUNCT! | International journal of clinical practice 20060301 |
| Potential for long-term remission of microprolactinoma after withdrawal of dopamine-agonist therapy. | Nature clinical practice. Endocrinology & metabolism 20060301 |
| Quinagolide--a valuable treatment option for hyperprolactinaemia. | European journal of endocrinology 20060201 |
| Cabergoline and mitral regurgitation. | The New England journal of medicine 20060126 |
| Obstructive hydrocephalus and intracranial hypertension caused by a giant macroprolactinoma. Prompt response to medical treatment. | Journal of neuro-oncology 20060101 |
| Efficacy and safety of high-dose cabergoline in Parkinson's disease. | Acta neurologica Scandinavica 20060101 |
| Effect of clarithromycin on the pharmacokinetics of cabergoline in healthy controls and in patients with Parkinson's disease. | Journal of pharmacological sciences 20060101 |
| Pharmacokinetic optimisation in the treatment of Parkinson's disease : an update. | Clinical pharmacokinetics 20060101 |
| Lisuride, a dopamine receptor agonist with 5-HT2B receptor antagonist properties: absence of cardiac valvulopathy adverse drug reaction reports supports the concept of a crucial role for 5-HT2B receptor agonism in cardiac valvular fibrosis. | Clinical neuropharmacology 20060101 |
| Management of restless legs syndrome in patients on dialysis. | Drugs 20060101 |
| Salvage of sildenafil failures with cabergoline: a randomized, double-blind, placebo-controlled study. | International journal of impotence research 20060101 |
| Persistent sexual side effects after SSRI discontinuation. | Psychotherapy and psychosomatics 20060101 |
| Treatment of Japanese restless legs syndrome patients with cabergoline: an open clinical preliminary trial. | Internal medicine (Tokyo, Japan) 20060101 |
| Development of a macroprolactinoma in association with hormone replacement therapy in a perimenopausal woman with presumed idiopathic hyperprolactinemia. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20060101 |
| Prostate response to prolactin in sexually active male rats. | Reproductive biology and endocrinology : RB&E 20060101 |
| Heart failure induced by non-cardiac drugs. | Drug safety 20060101 |
| New aspects in the diagnosis and treatment of Cushing disease. | Frontiers of hormone research 20060101 |
| Clinical and biochemical stabilization of Nelson's syndrome with long-term low-dose cabergoline treatment. | Pituitary 20060101 |
| Response variability in Attention-Deficit/Hyperactivity Disorder: a neuronal and glial energetics hypothesis. | Behavioral and brain functions : BBF 20060101 |
| A combination of oral cabergoline and double cloprostenol injections to produce third-quarter gestation termination in the bitch. | Journal of the American Animal Hospital Association 20060101 |
| Multiple endocrine neoplasia type 1. | Orphanet journal of rare diseases 20060101 |
| Hyper-IgG4 disease: report and characterisation of a new disease. | BMC medicine 20060101 |
| Somatostatin and dopamine-somatostatin multiple ligands directed towards somatostatin and dopamine receptors in pituitary adenomas. | Neuroendocrinology 20060101 |
| [Hyperprolactinemia: causes, diagnosis, and treatment]. | Endokrynologia Polska 20060101 |
| Prolactinoma in a diabetic dialysis patient with erectile dysfunction: a difficult differential diagnosis. | The review of diabetic studies : RDS 20060101 |
| Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation. | American journal of physiology. Endocrinology and metabolism 20051201 |
| Psychiatric aspects of organic sleep disorders. | Dialogues in clinical neuroscience 20051201 |
| A case of macroprolactinoma and elevated insulin-like growth factor-I in a young boy. | Acta paediatrica (Oslo, Norway : 1992) 20051201 |
| Cabergoline-related severe restrictive mitral regurgitation. | The New England journal of medicine 20051103 |
| Cystic macroprolactinoma: primary medical treatment? | Internal medicine journal 20051101 |
| Current pharmacotherapy for acromegaly: a review. | Expert opinion on pharmacotherapy 20051101 |
| [Inter- and intraindividual pharmacokinetic variations in the treatment of Parkinson's disease]. | Rinsho shinkeigaku = Clinical neurology 20051101 |
| [The role of dopaminagonists in the treatment of Parkinson's disease]. | Praxis 20051019 |
| Re-evaluation of the efficacy of the association of cabergoline to somatostatin analogues in acromegalic patients. | Clinical endocrinology 20051001 |
| Clinical inquiries. What is the recommended evaluation and treatment for elevated serum prolactin? | The Journal of family practice 20051001 |
| Treatment of pituitary tumors: dopamine agonists. | Endocrine 20051001 |
| [Dopamine-agonist resistant prolactinomas: diagnosis and management]. | Arquivos brasileiros de endocrinologia e metabologia 20051001 |
| Cabergoline: a safe, easy, cheap, and effective drug for prevention/treatment of ovarian hyperstimulation syndrome? | European journal of obstetrics, gynecology, and reproductive biology 20050901 |
| Low-dose levodopa therapy in Japanese patients with Parkinson's disease: a retrospective study. | Internal medicine (Tokyo, Japan) 20050901 |
| The clinical characteristics of headache in patients with pituitary tumours. | Brain : a journal of neurology 20050801 |
| Induction and synchronization of estrus in dogs. | Theriogenology 20050801 |
| Pegvisomant therapy in pituitary gigantism: successful treatment in a 12-year-old girl. | European journal of endocrinology 20050801 |
| Prolactin in the brushtail possum (Trichosurus vulpecula): development of homologous radioimmunoassay using recombinant possum prolactin. | General and comparative endocrinology 20050701 |
| Long-term remission following withdrawal of dopamine agonist therapy in subjects with microprolactinomas. | Clinical endocrinology 20050701 |
| Severe digital vasospasm caused by cabergoline. | Saudi medical journal 20050701 |
| Cabergoline plus lanreotide for ectopic Cushing's syndrome. | The New England journal of medicine 20050609 |
| [When and how should hyperprolactinemia be treated?]. | Presse medicale (Paris, France : 1983) 20050604 |
| The use of high-dose daily cabergoline in an adolescent patient with macroprolactinoma. | Journal of pediatric hematology/oncology 20050601 |
| Prediction of genotoxicity of chemical compounds by statistical learning methods. | Chemical research in toxicology 20050601 |
| Retrospective evaluation of cardio-pulmonary fibrotic side effects in symptomatic patients from a group of 234 Parkinson's disease patients treated with cabergoline. | Journal of neural transmission (Vienna, Austria : 1996) 20050501 |
| Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004. | Movement disorders : official journal of the Movement Disorder Society 20050501 |
| A case of postprandial cluster-like headache with prolactinoma: dramatic response to cabergoline. | Headache 20050501 |
| Agonism at 5-HT2B receptors is not a class effect of the ergolines. | European journal of pharmacology 20050425 |
| Effectiveness of adding dopamine agonist therapy to long-acting somatostatin analogues in the management of acromegaly. | European journal of endocrinology 20050401 |
| Dopamine agonist treatment before and after the birth reduces prolactin concentration but does not impair paternal responsiveness in Djungarian hamsters, Phodopus campbelli. | Hormones and behavior 20050301 |
| Randomized controlled pilot trial of cabergoline, hydergine and levodopa/carbidopa: Los Angeles Cocaine Rapid Efficacy Screening Trial (CREST). | Addiction (Abingdon, England) 20050301 |
| Cocaine Rapid Efficacy Screening Trials (CREST): lessons learned. | Addiction (Abingdon, England) 20050301 |
| Cocaine Rapid Efficacy Screening Trial (CREST): a paradigm for the controlled evaluation of candidate medications for cocaine dependence. | Addiction (Abingdon, England) 20050301 |
| Sleep episodes and daytime somnolence as result of individual susceptibility to different dopaminergic drugs in a PD patient: a polysomnographic study. | Journal of the neurological sciences 20050115 |
| Dopamine agonist cabergoline inhibits levodopa-induced caspase activation in 6-OHDA-lesioned mice. | Neuroscience research 20050101 |
| Differential modulation of microglia superoxide anion and thromboxane B2 generation by the marine manzamines. | BMC pharmacology 20050101 |
| Pharmacologic management of Cushing syndrome : new targets for therapy. | Treatments in endocrinology 20050101 |
| Role of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations. | Movement disorders : official journal of the Movement Disorder Society 20050101 |
| [Capacities of chemotherapy for pituitary tumors]. | Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko 20050101 |
| [Suppression of hyperprolactinemia in pituitary microadenoma with cabergoline (Dostinex)]. | Akusherstvo i ginekologiia 20050101 |
| [Possibilities of medical treatment in acromegaly]. | Casopis lekaru ceskych 20050101 |
| Spontaneous gonadotrophin deficiency recovery in an adult patient with Langerhans cell histiocytosis (LCH). | Pituitary 20050101 |
| Prolactinomas and pregnancy. | Pituitary 20050101 |
| PRL secreting adenomas in male patients. | Pituitary 20050101 |
| Pharmacologic resistance in prolactinoma patients. | Pituitary 20050101 |
| Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists. | Pituitary 20050101 |
| Non-functioning pituitary adenomas. | Journal of endocrinological investigation 20050101 |
| Diagnosis and Management of Multiple Endocrine Neoplasia Type 1 (MEN1). | Hereditary cancer in clinical practice 20050101 |
| Pramipexole in restless legs syndrome: an evidence-based review of its effectiveness on clinical outcomes. | Core evidence 20050101 |
| Restless legs: do they keep you awake? | Neurology 20041228 |
| Relief in sight for restless legs syndrome. | Neurology 20041228 |
| Effective cabergoline treatment in idiopathic restless legs syndrome. | Neurology 20041228 |
| Valvular heart disease and fibrotic reactions may be related to ergot dopamine agonists, but non-ergot agonists may also not be spared. | Movement disorders : official journal of the Movement Disorder Society 20041201 |
| Effect of cabergoline treatment on Cushing's disease caused by aberrant adrenocorticotropin-secreting macroadenoma. | Journal of endocrinological investigation 20041201 |
| A fatal overdose of the ergot derivative cabergoline. | Forensic science international 20041110 |
| Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table. | Movement disorders : official journal of the Movement Disorder Society 20041101 |
| Prolactin excess: treatment and toxicity. | Pediatric endocrinology reviews : PER 20041101 |
| [Recurrence of prolactinoma surveyed. Hormone therapy can safely be withdrawn for a long time in patients with normalized prolactin levels and invisible tumor]. | Lakartidningen 20041007 |
| Massive reduction of tumour load and normalisation of hyperprolactinaemia after high dose cabergoline in metastasised prolactinoma causing thoracic syringomyelia. | Journal of neurology, neurosurgery, and psychiatry 20041001 |
| Cardiopulmonary complications of ergot-derivative dopamine agonists. | The Journal of clinical psychiatry 20041001 |
| SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile. | The Journal of pharmacology and experimental therapeutics 20040901 |
| Dopamine receptor expression and function in human normal adrenal gland and adrenal tumors. | The Journal of clinical endocrinology and metabolism 20040901 |
| Drug treatment of Parkinson's disease. | Dialogues in clinical neuroscience 20040901 |
| Prolactin and reproductive medicine. | Current opinion in obstetrics & gynecology 20040801 |
| Constrictive pericarditis and pleuropulmonary fibrosis secondary to cabergoline treatment for Parkinson's disease. | Heart (British Cardiac Society) 20040801 |
| Cabergoline addition to depot somatostatin analogues in resistant acromegalic patients: efficacy and lack of predictive value of prolactin status. | Clinical endocrinology 20040801 |
| Diagnosis and management of galactorrhea. | American family physician 20040801 |
| Lifecorder: a new device for the long-term monitoring of motor activities for Parkinson's disease. | Internal medicine (Tokyo, Japan) 20040801 |
| Resolution of macroprolactinoma-induced symptomatic hydrocephalus following cabergoline therapy. | Age and ageing 20040701 |
| Cabergoline stimulates synthesis and secretion of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor by mouse astrocytes in primary culture. | Pharmacology 20040701 |
| Relevance of the MPTP primate model in the study of dyskinesia priming mechanisms. | Parkinsonism & related disorders 20040701 |
| Long-term safety and efficacy of cabergoline for the treatment of idiopathic restless legs syndrome: results from an open-label 6-month clinical trial. | Sleep 20040615 |
| Therapeutic factors causing hallucination in Parkinson's disease patients, especially those given selegiline. | Parkinsonism & related disorders 20040601 |
| Usefulness of switching to cabergoline from other dopamine agonists in patients with advanced Parkinson's disease. | Journal of neural transmission (Vienna, Austria : 1996) 20040601 |
| Prolactin and prostate hypertrophy: a pilot observational, prospective, case-control study in men with prolactinoma. | The Journal of clinical endocrinology and metabolism 20040601 |
| Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists. | Movement disorders : official journal of the Movement Disorder Society 20040601 |
| Cabergoline versus levodopa monotherapy. | Movement disorders : official journal of the Movement Disorder Society 20040601 |
| Re: Cabergoline versus levodopa monotherapy: a decision analysis. | Movement disorders : official journal of the Movement Disorder Society 20040601 |
| Synergistic inhibition of lipid peroxidation by vitamin E and a dopamine agonist, cabergoline. | Neurological research 20040601 |
| Induction of abortion in queens by administration of cabergoline (Galastop) solely or in combination with the PGF2alpha analogue Alfaprostol (Gabbrostim). | Theriogenology 20040501 |
| Dopamine receptor expression and function in corticotroph pituitary tumors. | The Journal of clinical endocrinology and metabolism 20040501 |
| Practice parameters for the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. | Sleep 20040501 |
| An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. | Sleep 20040501 |
| Prolactinoma presenting as painful postganglionic Horner syndrome. | Neurology 20040427 |
| MJA Practice Essentials--Endocrinology. 9: Pituitary disease in adults. | The Medical journal of Australia 20040419 |
| Contemporary management of prolactinomas. | Neurosurgical focus 20040415 |
| Pharmacological approach to the treatment of acromegaly. | Neurosurgical focus 20040415 |
| Cabergoline protects SH-SY5Y neuronal cells in an in vitro model of ischemia. | European journal of pharmacology 20040412 |
| Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: comparison with the effectiveness of cabergoline treatment. | The Journal of clinical endocrinology and metabolism 20040401 |
| Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis. | The Journal of clinical endocrinology and metabolism 20040401 |
| Prolactinomas. | The New England journal of medicine 20040304 |
| Prolactinomas. | The New England journal of medicine 20040304 |
| Six months of treatment with cabergoline restores sexual potency in hyperprolactinemic males: an open longitudinal study monitoring nocturnal penile tumescence. | The Journal of clinical endocrinology and metabolism 20040201 |
| The treatment of polycystic ovary syndrome. | Minerva ginecologica 20040201 |
| Cabergoline treatment of risperidone-induced hyperprolactinemia: a pilot study. | The Journal of clinical psychiatry 20040201 |
| Increased serum concentration of nerve growth factor in patients with microprolactinoma. | Neuropeptides 20040201 |
| Increased MIB-1/Ki-67 labeling index as a predictor of an aggressive course in a case of prolactinoma. | Hormone research 20040101 |
| Role of dopamine receptor agonists in the treatment of restless legs syndrome. | CNS drugs 20040101 |
| Shortening of interestrous intervals with cabergoline in bitches: a clinical trial. | Journal of the American Animal Hospital Association 20040101 |
| [Cabergoline for inhibition of lactation]. | Cirugia y cirujanos 20040101 |
| Acute onset of severe dilated cardiomyopathy during bromocriptine therapy. | The Annals of pharmacotherapy 20040101 |
| Agents in development for the management of cocaine abuse. | Drugs 20040101 |
| The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study. | CNS drugs 20040101 |
| Cabergoline : a review of its use in the treatment of Parkinson's disease. | Drugs 20040101 |
| [Prolactinoma and pregnancy]. | Akusherstvo i ginekologiia 20040101 |
| Gynaecomastia: is one cause enough? | The Netherlands journal of medicine 20040101 |
| Nelson's syndrome: complete remission with cabergoline but not with bromocriptine or cyproheptadine treatment. | Hormone research 20040101 |
| Cabergoline therapy of growth hormone & growth hormone/prolactin secreting pituitary tumors. | Pituitary 20040101 |
| Enhancement of the efficacy of weekly low-dose taxotere by the long acting anti-prolactinemic drug cabergoline in pretreated metastatic breast cancer. | Anticancer research 20040101 |
| Pituitary apoplexy during therapy with cabergoline in an adolescent male with prolactin-secreting macroadenoma. | Pituitary 20040101 |
| Cabergoline decreases somatotroph adenoma size: a case report. | Pituitary 20040101 |
| A novel 1297-1304delGCCTGCCA mutation in the exon 10 of the thyroid hormone receptor beta gene causes resistance to thyroid hormone. | Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology 20040101 |
| Biological response modifiers of cancer-related neuroendocrine disorders: efficacy of the long-term dopaminergic agonist cabergoline in the treatment of breast cancer-induced hyperprolactinemia. | Journal of biological regulators and homeostatic agents 20040101 |
| Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases. | Pituitary 20040101 |
| Evaluation of cabergoline and buserelin efficacy for oestrous induction in the bitch. | Reproduction in domestic animals = Zuchthygiene 20031201 |
| Effects of acute prolactin manipulation on sexual drive and function in males. | The Journal of endocrinology 20031201 |
| Chronic treatment with small doses of cabergoline prevents dopa-induced dyskinesias in parkinsonian monkeys. | Movement disorders : official journal of the Movement Disorder Society 20031201 |
| Cabergoline and silent aspiration in elderly patients with stroke. | Journal of the American Geriatrics Society 20031201 |
| [Clinical and therapeutic aspects of prolactinoma in men]. | Arquivos de neuro-psiquiatria 20031201 |
| Comparing dopamine agonists in Parkinson's disease. | Current opinion in neurology 20031201 |
| Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia. | The New England journal of medicine 20031120 |
| Cabergoline is an effective single-drug treatment for restless legs syndrome: clinical and actigraphic evaluation. | Sleep 20031101 |
| Improvement of sleep hypopnea by antiparkinsonian drugs in a patient with Parkinson's disease: a polysomnographic study. | Internal medicine (Tokyo, Japan) 20031101 |
| The effect of cabergoline on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson's disease. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20031001 |
| Hair loss induced by dopamine agonist: case report and review of the literature. | Parkinsonism & related disorders 20031001 |
| Current treatment options for restless legs syndrome. | Expert opinion on pharmacotherapy 20031001 |
| Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum. | Journal of neural transmission (Vienna, Austria : 1996) 20031001 |
| Bedtime cabergoline in Parkinson's disease patients with excessive daytime sleepiness induced by dopamine agonists. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20031001 |
| [Pharmacologic cure of a pituitary macroprolactinoma]. | Ginecologia y obstetricia de Mexico 20031001 |
| Clinical strategies to prevent and delay motor complications. | Neurology 20030923 |
| Restless legs syndrome. | The New England journal of medicine 20030821 |
| Paraquat leads to dopaminergic neural vulnerability in organotypic midbrain culture. | Neuroscience research 20030801 |
| Cabergoline versus levodopa monotherapy: a decision analysis. | Movement disorders : official journal of the Movement Disorder Society 20030801 |
| How effective are current therapies for acromegaly? | Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 20030801 |
| Coat colour changes associated with cabergoline administration in bitches. | The Journal of small animal practice 20030801 |
| Determination of cabergoline and L-dopa in human plasma using liquid chromatography-tandem mass spectrometry. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030715 |
| Dual dopamine agonist treatment in Parkinson's disease. | Journal of neurology 20030701 |
| High-sensitivity quantitation of cabergoline and pergolide using a triple-quadrupole mass spectrometer with enhanced mass-resolution capabilities. | Journal of mass spectrometry : JMS 20030701 |
| Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes. | Life sciences 20030620 |
| The increased utilisation of dopamine agonists and the introduction of COMT inhibitors have not reduced levodopa consumption--a nation-wide perspective in Sweden. | Parkinsonism & related disorders 20030601 |
| Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease. | Movement disorders : official journal of the Movement Disorder Society 20030601 |
| Dopamine agonist therapy for hyperprolactinemia. | Clinical obstetrics and gynecology 20030601 |
| Giant prolactinomas in men: efficacy of cabergoline treatment. | Clinical endocrinology 20030501 |
| Dihydroergocriptine in Parkinson's disease: clinical efficacy and comparison with other dopamine agonists. | Acta neurologica Scandinavica 20030501 |
| [Cabergoline in the treatment of Parkinson's disease]. | Neurologia (Barcelona, Spain) 20030501 |
| [Three patients with Parkinson's disease whose therapeutic levels were successfully improved after administration of quetiapine for suppression of psychosis]. | No to shinkei = Brain and nerve 20030501 |
| The assessment of cabergoline efficacy and tolerability in patients with pituitary prolactinoma type. | Polskie Archiwum Medycyny Wewnetrznej 20030501 |
| Somatostatin analogs in medical treatment of acromegaly. | Endocrine 20030401 |
| [Macroadenoma of the pituitary gland with moderate hyperprolactinaemia]. | Deutsche medizinische Wochenschrift (1946) 20030328 |
| Selective control of the estrous cycle of the dog through suppression of estrus and reduction of the length of anestrus. | Theriogenology 20030301 |
| Prolactinomas, dopamine agonists and headache: two case reports. | European journal of neurology 20030301 |
| Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia. | European journal of endocrinology 20030301 |
| Involvement of PI3'-K, mitogen-activated protein kinase and protein kinase B in the up-regulation of the expression of nNOSalpha and nNOSbeta splicing variants induced by PRL-receptor activation in GH3 cells. | Journal of neurochemistry 20030301 |
| Radioimmunoassay of prolactin for the meerkat (Suricata suricatta), a cooperatively breeding carnivore. | General and comparative endocrinology 20030201 |
| Treatment with cabergoline is associated with weight loss in patients with hyperprolactinemia. | Obesity research 20030201 |
| [Efficacy of cabergoline in the treatment of macroprolactinoma]. | Presse medicale (Paris, France : 1983) 20030118 |
| Accurate mass measurement at enhanced mass-resolution on a triple quadrupole mass-spectrometer for the identification of a reaction impurity and collisionally-induced fragment ions of cabergoline. | Rapid communications in mass spectrometry : RCM 20030101 |
| Hyperprolactinemia in men: clinical and biochemical features and response to treatment. | Endocrine 20030101 |
| Antiprolactinemic approach in the treatment of metastatic breast cancer: a phase II study of polyneuroendocrine therapy with LHRH-analogue, tamoxifen and the long-acting antiprolactinemic drug cabergoline. | Anticancer research 20030101 |
| [Arrest of lactation after 2nd trimester abortion with a single dose of cabergoline in comparison with 10-day administration of teguride]. | Ceska gynekologie 20030101 |
| Advances in the pharmacological management of Parkinson disease. | Journal of neural transmission. Supplementum 20030101 |
| Effects of acute administration of DA agonists on locomotor activity: MPTP versus neonatal intracerebroventricular 6-OHDA treatment. | Neurotoxicity research 20030101 |
| Clinical pharmacokinetics of cabergoline. | Clinical pharmacokinetics 20030101 |
| Cabergoline, pramipexole and ropinirole used as monotherapy in early Parkinson's disease: an evidence-based comparison. | Drugs & aging 20030101 |
| Addition of a dopamine agonist, cabergoline, to a serotonin-noradrenalin reuptake inhibitor, milnacipran as a therapeutic option in the treatment of refractory depression: two case reports. | Clinical neuropharmacology 20030101 |
| Visual vignette. Cabergoline therapy. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20030101 |
| [Long-term treatment with cabergoline in pregnancy and neonatal outcome: report of a clinical case]. | La Pediatria medica e chirurgica : Medical and surgical pediatrics 20030101 |
| Dopamine resistance of prolactinomas. | Pituitary 20030101 |
| The cost-effectiveness of early cabergoline treatment compared to levodopa in Sweden. | The European journal of health economics : HEPAC : health economics in prevention and care 20030101 |
| Hyperprolactinemia: pathophysiology and management. | Treatments in endocrinology 20030101 |
| Alopecia induced by dopamine agonists. | Neurology 20021224 |
| Cabergoline prevents necrotic neuronal death in an in vitro model of oxidative stress. | European journal of pharmacology 20021220 |
| Switch to quetiapine in antipsychotic agent-related hyperprolactinemia. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20021201 |
| Detecting dose-response using contrasts: asymptotic power and sample size determination for binomial data. | Statistics in medicine 20021130 |
| Dopamine agonist monotherapy in Parkinson's disease. | Lancet (London, England) 20021130 |
| Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes. | The Journal of pharmacology and experimental therapeutics 20021101 |
| Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)/alpha(2)-adrenoceptor. | The Journal of pharmacology and experimental therapeutics 20021101 |
| Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes. | The Journal of pharmacology and experimental therapeutics 20021101 |
| Effect of cabergoline on thyroid function in hyperprolactinaemia. | Clinical endocrinology 20021101 |
| Long term tolerability of high dose ergoline derived dopamine agonist therapy for the treatment of Parkinson's disease. | Journal of neurology, neurosurgery, and psychiatry 20021101 |
| Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome. | The Journal of clinical endocrinology and metabolism 20021101 |
| Cabergoline plasma concentration is increased during concomitant treatment with itraconazole. | Movement disorders : official journal of the Movement Disorder Society 20021101 |
| Hyperprolactinemia: etiology, diagnosis, and management. | Seminars in reproductive medicine 20021101 |
| A practical synthesis of cabergoline. | The Journal of organic chemistry 20021004 |
| The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma. | The Journal of clinical endocrinology and metabolism 20021001 |
| Use of the dopamine agonist cabergoline in the treatment of movement disorders. | Expert opinion on pharmacotherapy 20021001 |
| Autonomic failure mimicing dopamine agonist induced vertigo in a patient with macroprolactinoma. | Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20021001 |
| An evidence-based review of dopamine receptor agonists in the treatment of Parkinson's disease. | Saudi medical journal 20021001 |
| Circulating nitric oxide changes throughout the menstrual cycle in healthy women and women affected by pathological hyperprolactinemia on dopamine agonist therapy. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20021001 |
| Antioxidant properties of cabergoline: inhibition of brain auto-oxidation and superoxide anion production of microglial cells in rats. | Neuroscience letters 20020913 |
| Microstructure of the non-rapid eye movement sleep electroencephalogram in patients with newly diagnosed Parkinson's disease: effects of dopaminergic treatment. | Movement disorders : official journal of the Movement Disorder Society 20020901 |
| Gateways to Clinical Trials. | Methods and findings in experimental and clinical pharmacology 20020901 |
| Combination of two different dopamine agonists in the management of Parkinson's disease. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20020901 |
| Pregnancy termination in the bitch and queen. | Clinical techniques in small animal practice 20020801 |
| The dopamine agonist cabergoline provides neuroprotection by activation of the glutathione system and scavenging free radicals. | Neuroscience research 20020701 |
| Sleep attacks in patients taking dopamine agonists: review. | BMJ (Clinical research ed.) 20020622 |
| SUNCT syndrome in two patients with prolactinomas and bromocriptine-induced attacks. | Neurology 20020611 |
| Dopamine receptor agonists for treating prolactinomas. | Expert opinion on investigational drugs 20020601 |
| Use of cabergoline to treat primary and secondary anestrus in dogs. | Journal of the American Veterinary Medical Association 20020601 |
| [Novel pharmacologic therapies in acromegaly]. | Orvosi hetilap 20020512 |
| Cabergoline can increase penile erections and libido. | Neurology 20020312 |
| Long-term studies of dopamine agonists. | Neurology 20020226 |
| Restless legs syndrome: treatment with dopaminergic agents. | Neurology 20020226 |
| Giant prolactinomas presenting as skull base tumors. | Surgical neurology 20020201 |
| Macroprolactinoma associated with Cushing's disease, successfully treated with cabergoline. | Journal of endocrinological investigation 20020201 |
| A case of macroprolactinoma with subclinical growth hormone production. | Endocrine journal 20020201 |
| Effects of short- and long-acting dopamine agonists on sensitized dopaminergic neurotransmission in rats with unilateral 6-OHDA lesions. | Life sciences 20020118 |
| Is cabergoline a better drug to inhibit lactation in patients with psychotic symptoms? | Journal of psychiatry & neuroscience : JPN 20020101 |
| Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment. | Progress in neuro-psychopharmacology & biological psychiatry 20020101 |
| Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease. | Clinical pharmacokinetics 20020101 |
| Control of fertility in the red fox (Vulpes vulpes): effect of a single oral dose of cabergoline in early pregnancy. | Reproduction, fertility, and development 20020101 |
| Treatment of Parkinson's disease and restless legs syndrome with cabergoline, a long-acting dopamine agonist. | International journal of clinical practice 20020101 |
| DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease. | Movement disorders : official journal of the Movement Disorder Society 20020101 |
| DA agonists -- ergot derivatives: cabergoline: management of Parkinson's disease. | Movement disorders : official journal of the Movement Disorder Society 20020101 |
| Assessment of cabergoline as a reproductive inhibitor in coyotes (Canis latrans). | Reproduction (Cambridge, England) Supplement 20020101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20020101 |
| [Use of dopamine agonists in the treatment of Parkinson's disease]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20020101 |
| Pregnancy outcome after cabergoline treatment in early weeks of gestation. | Reproductive toxicology (Elmsford, N.Y.) 20020101 |
| Medical management of prolactin-secreting pituitary adenomas. | Pituitary 20020101 |
| Medical management of growth hormone-secreting pituitary adenomas. | Pituitary 20020101 |
| Current status and future opportunities for controlling acromegaly. | Pituitary 20020101 |
| Medical therapy of macroprolactinomas in males: I. Prevalence of hypopituitarism at diagnosis. II. Proportion of cases exhibiting recovery of pituitary function. | Pituitary 20020101 |
| Falsely low serum prolactin in two cases of invasive macroprolactinoma. | Pituitary 20020101 |
| A review of canine pseudocyesis. | Reproduction in domestic animals = Zuchthygiene 20011201 |
| Cabergoline influences ovarian stimulation in hyperprolactinaemic patients with polycystic ovary syndrome. | Human reproduction (Oxford, England) 20011101 |
| Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy. | The Journal of clinical endocrinology and metabolism 20011101 |
| Determination of cabergoline by electrospray ionization tandem mass spectrometry: picogram detection via column focusing sample introduction. | Analytical chemistry 20011015 |
| Effectiveness of cabergoline for termination of pregnancy in silver fox (Vulpes vulpes fulva). | Reproduction in domestic animals = Zuchthygiene 20011001 |
| Disorders of prolactin secretion. | Endocrinology and metabolism clinics of North America 20010901 |
| Cabergoline, a hopeful medicine for prolactinomas and non-tumoral hyperprolactinemia. | Internal medicine (Tokyo, Japan) 20010901 |
| Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients. | Internal medicine (Tokyo, Japan) 20010901 |
| [A case of elderly onset Parkinson's disease complicated by dropped head syndrome]. | Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 20010901 |
| Upregulation of lymphocyte apoptosis as a strategy for preventing and treating autoimmune disorders: a role for whole-food vegan diets, fish oil and dopamine agonists. | Medical hypotheses 20010801 |
| Effects of dopamine d2 receptor agonists in a pituitary transplantation-induced hyperprolactinaemia/anovulation model in rats. | Clinical and experimental pharmacology & physiology 20010801 |
| Ovarian hyperstimulation without elevated serum estradiol associated with pure follicle-stimulating hormone-secreting pituitary adenoma. | The Journal of clinical endocrinology and metabolism 20010801 |
| Minor tumour shrinkage in nonfunctioning pituitary adenomas by long-term treatment with the dopamine agonist cabergoline. | Pituitary 20010801 |
| Successful treatment of a large macroprolactinoma with cabergoline during pregnancy. | Pituitary 20010801 |
| Control of red fox (Vulpes vulpes) fertility with cabergoline: dose response and timing of intervention. | Reproduction (Cambridge, England) 20010701 |
| Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method. | The Journal of clinical endocrinology and metabolism 20010601 |
| [Pharmacological effects of cabergoline against parkinsonism]. | Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20010601 |
| Study of the change of prolactin and progesterone during dopaminergic agonist treatments in pseudopregnant bitches. | Animal reproduction science 20010531 |
| Sudden daytime sleep onset in Parkinson's disease: polysomnographic recordings. | Movement disorders : official journal of the Movement Disorder Society 20010501 |
| In vivo and in vitro effects of octreotide, quinagolide and cabergoline in four hyperprolactinaemic acromegalics: correlation with somatostatin and dopamine D2 receptor scintigraphy. | Clinical endocrinology 20010401 |
| Polycystic ovary syndrome and hyperprolactinemia. | Obstetrics and gynecology clinics of North America 20010301 |
| Cabergoline-induced CSF rhinorrhea in patients with macroprolactinoma. Report of three cases. | Journal of endocrinological investigation 20010301 |
| Long-term treatment of thyrotropin-secreting microadenoma with lanreotide and cabergoline. | European journal of endocrinology 20010201 |
| Control of unremitting rheumatoid arthritis by the prolactin antagonist cabergoline. | Rheumatology (Oxford, England) 20010201 |
| Pituitary adenomas in childhood and adolescence. Clinical analysis of 10 cases. | Journal of endocrinological investigation 20010201 |
| In vivo secretory potential and the effect of combination therapy with octreotide and cabergoline in patients with clinically non-functioning pituitary adenomas. | Clinical endocrinology 20010101 |
| Tumour shrinkage and chiasmal herniation after successful cabergoline treatment for a macroprolactinoma. | Clinical endocrinology 20010101 |
| ACTH silent adenoma shrinking under cabergoline. | European journal of endocrinology 20010101 |
| A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy. | Journal of neural transmission (Vienna, Austria : 1996) 20010101 |
| Cabergoline for levodopa-induced complications in Parkinson's disease. | The Cochrane database of systematic reviews 20010101 |
| Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease. | The Cochrane database of systematic reviews 20010101 |
| Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model. | Advances in neurology 20010101 |
| Clusterlike headache as first manifestation of a prolactinoma. | Headache 20010101 |
| Actigraph analysis of diurnal motor fluctuations during dopamine agonist therapy. | European neurology 20010101 |
| Efficacy of cabergoline in long-term use: results of three observational studies in 1,500 patients with Parkinson's disease. | European neurology 20010101 |
| Clinical data on restless legs syndrome: a dose-finding study with cabergoline. | European neurology 20010101 |
| [Dostinex - the most effective medicine for inhibition of postpartal lactation]. | Akusherstvo i ginekologiia 20010101 |
| Treatment of risperidone-induced hyperprolactinemia with a dopamine agonist in children. | Journal of child and adolescent psychopharmacology 20010101 |
| Prolactinomas in children and adolescents--consequences in adult life. | Journal of pediatric endocrinology & metabolism : JPEM 20010101 |
| Bait-delivered cabergoline for the reproductive control of the red fox (Vulpes vulpes): estimating mammalian non-target risk in south-eastern Australia. | Reproduction, fertility, and development 20010101 |
| Use of the dopamine agonists bromocriptine and cabergoline in the management of risperidone-induced hyperprolactinemia in patients with psychotic disorders. | Journal of endocrinological investigation 20001201 |
| Hepatolithiasis (intrahepatic stone) during octreotide therapy for acromegaly: a case report. | Pituitary 20001201 |
| The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas. | Clinical endocrinology 20000701 |
| Clinical pharmacology of dopamine agonists. | Pharmacotherapy 20000101 |
| Sustained cabergoline treatment reverses levodopa-induced dyskinesias in parkinsonian monkeys. | Clinical neuropharmacology 20000101 |
| Cushing's syndrome in pregnancy treated by ketoconazole: case report and review of the literature. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 19990601 |
| Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists. | Journal of neurochemistry 19990201 |
| Effect of cabergoline, a long-acting dopamine D2 agonist, on reserpine-treated rodents. | Biological & pharmaceutical bulletin 19961101 |
| Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum. | The European journal of neuroscience 19960201 |
| Effect of cabergoline, a dopamine agonist, on estrogen-induced rat pituitary tumors: in vitro culture studies. | Endocrine journal 19950601 |
| Reduction in the size of prolactin-producing pituitary tumor after Cabergoline administration. | Fertility and sterility 19890901 |
| Long-lasting prolactin-lowering effect of cabergoline, a new dopamine agonist, in hyperprolactinemic patients. | The Journal of clinical endocrinology and metabolism 19861001 |